SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE

Reduce your risk when donating: see where the money actually goes.

Reduce your risk when donating: see where the money actually goes.

Cite this

Plain text SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE. furp.org, nonprofit organization profile, tax years 2010–2024. https://furp.org/org/sanford-burnham-prebys-medical-discovery-institute-510197108. Retrieved 2026-11-20.

APA furp.org. (n.d.). SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE [Nonprofit organization profile; tax years 2010–2024]. Retrieved November 20, 2026, from https://furp.org/org/sanford-burnham-prebys-medical-discovery-institute-510197108

MLA “SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE.” furp.org, tax years 2010–2024, https://furp.org/org/sanford-burnham-prebys-medical-discovery-institute-510197108. Accessed 20 Nov. 2026.

Retrieved 2026-11-20; covers tax years 2010–2024. Data: furp.org (index © the FURP Alliance; the records are public domain).

Related institution: Sanford Burnham Prebys Medical Discovery Institute Exact

2024 · Form 990 · revenue $114.4M ($117.4M in 2025 dollars) · expenses $116.1M · assets $338.0M

Also known as
INSTITUTE
EIN
51-0197108
Address
10901 N TORREY PINES RD, LA JOLLA, CA 92037-1005
Website
WWW.SBPDISCOVERY.ORG
NTEE code
H92 Biomedicine, Bioengineering Research (Medical Research) published (IRS Business Master File, as H920)
FURP topic
abuse: substance · men: issues · science: research education · space: outer · survivor: cancer (from its 990 text; the topic index)
Exempt type
501(c)(3): charitable, religious, educational, scientific or literary (corporation)
Ruling date
August 1982 (when the IRS recognized its exemption)
IRS status
Exempt (unconditional) (IRS Business Master File) IRS data ↗
Tax-deductible donations
Yes: listed in IRS Publication 78 (public charity) Pub 78 ↗
Foundation status
Public charity, 509(a)(2)
Cross-check
ProPublica Nonprofit Explorer

Mission

SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE'S MISSION IS TO ADVANCE THE BIOMEDICAL SCIENCES BY CULTIVATING THE NEXT GENERATION OF SCIENTIFIC LEADERS, PROVIDING MEANINGFUL OPPORTUNITIES FOR RESEARCHERS OF ALL BACKGROUNDS TO LEARN, INNOVATE, AND MAKE BREAKTHROUGH DISCOVERIES THAT IMPROVE HUMAN HEALTH.

Each tax year counts once: when a return was amended, only the latest return for that period is used below (superseded returns stay listed, greyed, under Finances).

People paid by the organization

36 people paid across every filing: current people first, then by total pay from this organization. Organizations counts every nonprofit each person appears on.

NameLatest titleYearsLatest year payTotal pay from hereOrganizations
Kristiina Vuori Md Phd PROFESSOR2010-2024 $665,672$19,562,372 3
Carl Ware Phd CENTER DIRECTOR, IIDC2010-2024 $514,299$6,583,448 1
Michael Jackson Phd DRUG DISCOVERY & DEV, SR VP2014-2024 $509,673$4,812,103 1
David Brenner CEO & PRESIDENT2022-2024 $1,345,526$3,001,736 7
Robin Ryan CFO & TREASURER (THRU 11/15/24)2022-2024 $465,431$1,284,524 1
Jamey Marth Phd PROGRAM DIRECTOR2022-2024 $468,110$1,020,448 1
Adrienne Crown Jd GENERAL COUNSEL & SECRETARY2022-2024 $361,604$1,015,688 1
Nicholas Cosford PROFESSOR & TRUSTEE2022-2024 $384,321$1,005,370 1
Peter Adams Phd PROGRAM DIRECTOR2024 $534,247$534,247 1
Michael Jones CFO & TREASURER (AS OF OCT 2024)2024 $73,105$73,105 1
C Randal Mills Phd (former) FORMER CEO2020-2023 $341,250$7,491,594 1
Perry Nisen (former) FORMER CEO2014-2018 $780,458$5,007,688 1
Daniel Kelly Md (former) CENTER DIR/SCI DIR AT LK NONA2010-2017 $646,868$4,451,586 1
Garth Powis Phd (former) CENTER DIRECTOR2014-2020 $515,516$3,849,706 1
John C Reed Md Phd (former) FORMER CEO2010-2013 -$968,401$2,959,254 2
Ze'Ev Ronai Phd (former) CENTER DIRECTOR2015-2023 $561,192$2,836,375 2
Stuart Lipton Md Phd (former) CENTER DIRECTOR2010-2014 $505,824$2,610,514 1
Gary F Raisl Edd (former) EVP/CAO/CFO/TREASURER2010-2013 $507,741$2,149,658 1
Jorge Moscat Phd (former) PROGRAM DIRECTOR2011-2019 $486,913$1,905,084 1
Randal Kaufman Phd (former) PROGRAM DIRECTOR2018-2023 $477,988$1,794,762 1
Gary Chessum (former) CFO (THRU 7/31/2018)2015-2018 $249,273$1,466,967 1
Gary Raisl Ed D (former) FORMER EVP/CAO/CFP/TREASURER2014-2016 $365,372$1,345,866 1
Edward Lewandowski (former) PROFESSOR2016-2017 $705,980$1,248,475 1
Louis R Coffman (former) CAO & CFO2018-2020 $446,066$1,152,854 3
Paul Laikind Phd (former) SR VP CBO2010-2011 $528,269$915,060 3
Amar Duvvur (former) CFO (THRU 08/22)2021-2022 $493,113$914,478 1
Edgar Gillenwaters (former) VP EXTERNAL RELATIONS2010-2011 $335,991$693,712 1
Margaret Dunbar Jd (former) SECRETARY/SR DIRECTOR IP2011-2013 $189,852$563,261 1
Christine Dittmer (former) CHIEF DEVELOPMENT OFFICER2022 $532,827$532,827 1
Scott Tocher (former) CORPORATE SECRETARY (PART YEAR)2021-2022 $246,670$448,858 1
Chun Jerold Phd (former) PROFESSOR2021 $413,760$413,760 1
Blair Blum (former) SR VP, EXTERNAL RELATIONS2010 $363,794$363,794 1
Dwight Towler (former) PROGRAM DIRECTOR2013 $350,759$350,759 1
Cyril Doucet (former) VP, ADMIN. AT LAKE NONA2012 $342,982$342,982 1
Tariq Rana Phd (former) PROGRAM DIRECTOR2011 $327,304$327,304 1
Fred Levine Md Phd (former) TRUSTEE/CENTER DIRECTOR2010 $244,495$244,495 1

Officers and directors, no compensation reported

69 people listed on the returns with $0 (or no amount) in every compensation column: current people first. Hours are as filed on the latest return each person appears on.

NameLatest titleYearsHrs/wk (latest)CompensationOrganizations
Donald Kearns CHAIR2021-2024 1 $0 reported 7
William Gerhart TRUSTEE2013-2024 1 $0 reported 1
Daniel J Epstein TRUSTEE2011-2024 1 $0 reported 1
David L Szekeres Jd TRUSTEE2019-2024 1 $0 reported 1
David W Down TRUSTEE2013-2024 1 $0 reported 8
Douglas H Obenshain TRUSTEE2010-2024 1 $0 reported 1
Katherine Chapin TRUSTEE2020-2024 1 $0 reported 1
Kazumi Shiosaki Phd TRUSTEE2016-2024 1 $0 reported 1
Lonna J Williams Stolper TRUSTEE2023-2024 1 $0 reported 1
Lori Moore VICE CHAIR2023-2024 1 $0 reported 1
Michael R Cunningham TRUSTEE (THRU 11/1/24)2023-2024 1 $0 reported 1
Stuart Tanz TRUSTEE2010-2024 1 $0 reported 1
Ted Roth TRUSTEE2023-2024 1 $0 reported 6
William Roper TRUSTEE2018-2024 1 $0 reported 1
James C Blair Phd (former) TRUSTEE (PART YEAR)2012-2023 1 $0 reported 1
James M Myers (former) TRUSTEE (PART YEAR)2016-2023 1 $0 reported 1
James E Jardon Ii (former) TRUSTEE (PART YEAR)2021-2022 1 $0 reported 1
Karen S Haynes (former) TRUSTEE (PART YEAR)2019-2022 1 $0 reported 4
Matthew Browne (former) TRUSTEE (PART YEAR)2018-2022 1 $0 reported 1
Anna Barker Phd (former) TRUSTEE (PART YEAR)2017-2021 1 $0 reported 1
Henry Nordoff (former) TRUSTEE (PART YEAR)2012-2021 1 $0 reported 1
Dan Epstein (former) TRUSTEE2019-2020 1 $0 reported 2
Knox Bell (former) CORPORATE SECRETARY2014-2020 2 $0 reported 2
Donald Kerns Phd (former) TRUSTEE2019-2020 1 $0 reported 1
James Jardon (former) TRUSTEE2011-2020 1 $0 reported 1
Peter Seidler (former) TRUSTEE (PART YEAR)2017-2020 1 $0 reported 1
Jeanne Herberger (former) TRUSTEE (PART YEAR)2010-2019 1 $0 reported 1
Alan Gleicher (former) TRUSTEE (PART YEAR)2010-2018 1 $0 reported 1
Donald Rosenberg (former) TRUSTEE (PART YEAR)2016-2018 1 $0 reported 1
David Szekered (former) TRUSTEE2018 1 $0 reported 1
Carol Gallagher (former) TRUSTEE (PART YEAR)2015-2017 1 $0 reported 3
Greg Lucier (former) TRUSTEE (PART YEAR)2010-2017 1 $0 reported 2
Wainwright Fishburn (former) TRUSTEE (PART YEAR)2013-2017 1 $0 reported 2
Luder Whitlock (former) TRUSTEE (PART YEAR)2013-2017 1 $0 reported 1
Lorenzo Berho (former) TRUSTEE (PART YEAR)2011-2017 1 $0 reported 1
Donald Jernigan (former) TRUSTEE (PART YEAR)2014-2017 1 $0 reported 1
Edward Schulak (former) TRUSTEE (PART YEAR)2014-2017 1 $0 reported 1
Bernard Machen (former) TRUSTEE (PART YEAR)2012-2016 1 $0 reported 1
Rasesh Thakkar (former) TRUSTEE (PART YEAR)2013-2016 1 $0 reported 1
Patrick Geraghty (former) TRUSTEE (PART YEAR)2012-2016 1 $0 reported 1
Doug Manchester (former) TRUSTEE (PART YEAR)2015-2016 1 $0 reported 1
Pauline Foster (former) TRUSTEE (PART YEAR)2010-2016 1 $0 reported 1
Andrew Viterbi (former) TRUSTEE (PART YEAR)2010-2014 1 $0 reported 2
Peter Preuss (former) TRUSTEE (PART YEAR)2010-2014 1 $0 reported 5
Brent Jacobs (former) TRUSTEE (PART YEAR)2010-2014 1 $0 reported 2
Papa Doug Manchester (former) TRUSTEE2014 1 $0 reported 1
Allen Weiss (former) TRUSTEE (PART YEAR)2011-2014 1 $0 reported 1
Gayle Wilson (former) TRUSTEE (PART YEAR)2010-2014 1 $0 reported 1
Shehan Dissanayake (former) TRUSTEE2011-2013 1 $0 reported 1
Wain Fishburn (former) TRUSTEE/CHAIRMAN2010-2012 1 $0 reported 2
Duane Roth (former) TRUSTEE2012 1 $0 reported 5
Robert Lauer (former) TRUSTEE2010-2012 1 $0 reported 1
Nicolas Nierenberg (former) TRUSTEE2010-2012 1 $0 reported 1
Jan Tuttleman (former) TRUSTEE2010-2012 1 $0 reported 1
David F Hale (former) TRUSTEE2010-2011 1 $0 reported 11
Arthur Brody (former) TRUSTEE2010-2011 1 $0 reported 1
Robert Mandell (former) TRUSTEE2010-2011 1 $0 reported 1
Duanne Roth (former) TRUSTEE2011 1 $0 reported 1
Barbara Warren (former) TRUSTEE2010-2011 1 $0 reported 1
Diane Winokur (former) TRUSTEE2010-2011 1 $0 reported 1
Malin Burnham (former) TRUSTEE2010 1 $0 reported 15
Bridgette Bren (former) TRUSTEE2010 1 $0 reported 1
Shehan Dissanyake (former) TRUSTEE2010 1 $0 reported 1
Jeannie Fontana (former) TRUSTEE2010 1 $0 reported 1
Jim Jardon (former) TRUSTEE2010 1 $0 reported 1
Sheila Lipinsky (former) TRUSTEE2010 1 $0 reported 1
Douglas Manchester (former) TRUSTEE2010 1 $0 reported 1
Alan Weiss (former) TRUSTEE2010 1 $0 reported 1
Ken Woolcott (former) TRUSTEE2010 1 $0 reported 1

People by year

2024 · 24 people listed · 10 paid, $5.3M · 611 employees · 14 volunteers
NameTitleHrs/wkFrom orgFrom relatedOtherTotalOrgs
DAVID BRENNER CEO & PRESIDENT50 $994,322$0$351,204 $1,345,5267
KRISTIINA VUORI MD PHD PROFESSOR50 $602,266$0$63,406 $665,6723
PETER ADAMS PHD PROGRAM DIRECTOR50 $450,347$0$83,900 $534,2471
CARL WARE PHD CENTER DIRECTOR, IIDC50 $449,559$0$64,740 $514,2991
MICHAEL JACKSON PHD DRUG DISCOVERY & DEV, SR VP50 $443,835$0$65,838 $509,6731
JAMEY MARTH PHD PROGRAM DIRECTOR50 $399,446$0$68,664 $468,1101
ROBIN RYAN CFO & TREASURER (THRU 11/15/24)50 $414,770$0$50,661 $465,4311
NICHOLAS COSFORD PROFESSOR & TRUSTEE50 $305,473$0$78,848 $384,3211
ADRIENNE CROWN JD GENERAL COUNSEL & SECRETARY50 $313,425$0$48,179 $361,6041
MICHAEL JONES CFO & TREASURER (AS OF OCT 2024)50 $67,222$0$5,883 $73,1051
DONALD KEARNS CHAIR1 $0$0$0 $07
LORI MOORE VICE CHAIR1 $0$0$0 $01
MICHAEL R CUNNINGHAM TRUSTEE (THRU 11/1/24)1 $0$0$0 $01
DAVID W DOWN TRUSTEE1 $0$0$0 $08
DANIEL J EPSTEIN TRUSTEE1 $0$0$0 $01
WILLIAM GERHART TRUSTEE1 $0$0$0 $01
DOUGLAS H OBENSHAIN TRUSTEE1 $0$0$0 $01
WILLIAM ROPER TRUSTEE1 $0$0$0 $01
TED ROTH TRUSTEE1 $0$0$0 $06
KAZUMI SHIOSAKI PHD TRUSTEE1 $0$0$0 $01
LONNA J WILLIAMS STOLPER TRUSTEE1 $0$0$0 $01
DAVID L SZEKERES JD TRUSTEE1 $0$0$0 $01
STUART TANZ TRUSTEE1 $0$0$0 $01
KATHERINE CHAPIN TRUSTEE1 $0$0$0 $01
2023 · 26 people listed · 10 paid, $5.6M · 594 employees · 16 volunteers
NameTitleHrs/wkFrom orgFrom relatedOtherTotalOrgs
DAVID BRENNER MD CEO AND PRESIDENT50 $984,345$0$327,443 $1,311,7887
KRISTIINA VUORI MD PHD PROFESSOR50 $601,208$0$60,610 $661,8183
ZE'EV RONAI PHD CENTER DIRECTOR50 $497,532$0$63,660 $561,1922
CARL WARE PHD CENTER DIRECTOR, IIDC50 $454,389$0$63,702 $518,0911
ROBIN RYAN CFO & TREASURER50 $458,690$0$48,299 $506,9891
MICHAEL JACKSON PHD DRUG DISCOVERY & DEV, SR VP50 $447,238$0$58,573 $505,8111
RANDAL KAUFMAN PHD PROGRAM DIRECTOR50 $402,033$0$75,955 $477,9881
ADRIENNE CROWN JD GENERAL COUNSEL & SECRETARY50 $360,490$0$48,673 $409,1631
C RANDAL MILLS PHD FORMER CEO0 $341,250$0$0 $341,2501
NICHOLAS COSFORD PROFESSOR & TRUSTEE50 $244,128$0$68,484 $312,6121
DONALD B KEARNS MD VICE CHAIRMAN1 $0$0$0 $07
WILLIAM GERHART CHAIRMAN1 $0$0$0 $01
DANIEL J EPSTEIN TRUSTEE1 $0$0$0 $01
DAVID L SZEKERES JD TRUSTEE1 $0$0$0 $01
DAVID W DOWN TRUSTEE1 $0$0$0 $08
DOUGLAS H OBENSHAIN TRUSTEE1 $0$0$0 $01
JAMES C BLAIR PHD TRUSTEE (PART YEAR)1 $0$0$0 $01
JAMES M MYERS TRUSTEE (PART YEAR)1 $0$0$0 $01
KATHERINE CHAPIN TRUSTEE1 $0$0$0 $01
KAZUMI SHIOSAKI PHD TRUSTEE1 $0$0$0 $01
LONNA J WILLIAMS STOLPER TRUSTEE1 $0$0$0 $01
LORI MOORE TRUSTEE1 $0$0$0 $01
MICHAEL R CUNNINGHAM TRUSTEE1 $0$0$0 $01
STUART A TANZ TRUSTEE1 $0$0$0 $01
TED ROTH TRUSTEE1 $0$0$0 $06
WILLIAM A ROPER TRUSTEE1 $0$0$0 $01
2022 · 27 people listed · 12 paid, $9.8M · 624 employees · 15 volunteers
NameTitleHrs/wkFrom orgFrom relatedOtherTotalOrgs
C RANDAL MILLS PHD FORMER CEO0 $4,979,417$0$46,642 $5,026,0591
KRISTIINA VUORI MD PHD PROFESSOR & FORMER PRESIDENT50 $710,798$0$55,967 $766,7653
JAMEY MARTH PHD PROGRAM DIRECTOR50 $494,296$0$58,042 $552,3381
CHRISTINE DITTMER CHIEF DEVELOPMENT OFFICER50 $500,215$0$32,612 $532,8271
ZE'EV RONAI PHD CENTER DIRECTOR50 $440,033$0$67,963 $507,9962
CARL WARE PHD CENTER DIRECTOR, IIDC50 $445,990$0$58,835 $504,8251
AMAR DUVVUR CFO (THRU 08/22)50 $463,528$0$29,585 $493,1131
DAVID BRENNER MD CEO AND PRESIDENT (AS OF 09/2022)50 $252,575$0$91,847 $344,4227
ROBIN RYAN CFO & TREASURER50 $272,541$0$39,563 $312,1041
NICHOLAS COSFORD PROFESSOR & TRUSTEE50 $243,409$0$65,028 $308,4371
SCOTT TOCHER CORPORATE SECRETARY (PART YEAR)50 $236,687$0$9,983 $246,6701
ADRIENNE CROWN GENERAL COUNSEL & SECRETARY50 $213,256$0$31,665 $244,9211
DONALD B KEARNS PHD VICE CHAIRMAN1 $0$0$0 $07
WILLIAM GERHART CHAIRMAN1 $0$0$0 $01
DANIEL J EPSTEIN TRUSTEE1 $0$0$0 $01
DAVID L SZEKERES TRUSTEE1 $0$0$0 $01
DAVID W DOWN TRUSTEE1 $0$0$0 $08
DOUGLAS H OBENSHAIN TRUSTEE1 $0$0$0 $01
JAMES C BLAIR PHD TRUSTEE1 $0$0$0 $01
JAMES E JARDON II TRUSTEE (PART YEAR)1 $0$0$0 $01
JAMES M MYERS TRUSTEE1 $0$0$0 $01
KAREN S HAYNES TRUSTEE (PART YEAR)1 $0$0$0 $04
KATHERINE CHAPIN TRUSTEE1 $0$0$0 $01
KAZUMI SHIOSAKI PHD TRUSTEE1 $0$0$0 $01
MATTHEW BROWNE TRUSTEE (PART YEAR)1 $0$0$0 $01
STUART A TANZ TRUSTEE1 $0$0$0 $01
WILLIAM A ROPER TRUSTEE1 $0$0$0 $01
2021 · 26 people listed · 9 paid, $5.5M · 645 employees · 15 volunteers
NameTitleHrs/wkFrom orgFrom relatedOtherTotalOrgs
C RANDAL MILLS PHD CEO (PART YEAR)50 $1,190,319$0$268,556 $1,458,8751
KRISTIINA VUORI MD PHD PRESIDENT50 $986,151$0$53,567 $1,039,7183
ZE'EV RONAI PHD CENTER DIRECTOR50 $449,551$0$68,556 $518,1072
MICHAEL JACKSON PHD DRUG DISCOVERY & DEV, SR VP50 $448,253$0$60,058 $508,3111
CARL WARE PHD CENTER DIRECTOR, IIDC50 $450,942$0$45,465 $496,4071
RANDAL KAUFMAN PHD PROGRAM DIRECTOR50 $378,919$0$65,980 $444,8991
AMAR DUVVUR CFO50 $412,421$0$8,944 $421,3651
CHUN JEROLD PHD PROFESSOR50 $360,136$0$53,624 $413,7601
SCOTT TOCHER GENERAL COUNSEL & CORPORATE SECRETARY50 $194,719$0$7,469 $202,1881
JAMES C BLAIR PHD CHAIRMAN1 $0$0$0 $01
WILLIAM GERHART VICE CHAIRMAN1 $0$0$0 $01
ANNA BARKER PHD TRUSTEE (PART YEAR)1 $0$0$0 $01
DANIEL J EPSTEIN TRUSTEE1 $0$0$0 $01
DAVID L SZEKERES TRUSTEE1 $0$0$0 $01
DAVID W DOWN TRUSTEE1 $0$0$0 $08
DONALD B KEARNS PHD TRUSTEE1 $0$0$0 $07
DOUGLAS H OBENSHAIN TRUSTEE1 $0$0$0 $01
HENRY NORDOFF TRUSTEE (PART YEAR)1 $0$0$0 $01
JAMES E JARDON II TRUSTEE1 $0$0$0 $01
JAMES M MYERS TRUSTEE1 $0$0$0 $01
KAREN S HAYNES TRUSTEE1 $0$0$0 $04
KATHERINE CHAPIN TRUSTEE1 $0$0$0 $01
KAZUMI SHIOSAKI PHD TRUSTEE1 $0$0$0 $01
MATTHEW BROWNE TRUSTEE1 $0$0$0 $01
STUART A TANZ TRUSTEE1 $0$0$0 $01
WILLIAM A ROPER TRUSTEE1 $0$0$0 $01
2020 · 27 people listed · 8 paid, $6.1M · 696 employees · 19 volunteers
NameTitleHrs/wkFrom orgFrom relatedOtherTotalOrgs
KRISTIINA VUORI MD PHD PRESIDENT50 $2,599,463$0$53,106 $2,652,5693
C RANDAL MILLS PHD CEO50 $564,836$0$100,574 $665,4101
GARTH POWIS PHD CENTER DIRECTOR50 $464,625$0$50,891 $515,5161
MICHAEL JACKSON PHD DRUG DISCOVERY & DEV, SR VP50 $418,564$0$56,754 $475,3181
CARL WARE PHD CENTER DIRECTOR, IIDC50 $405,773$0$55,843 $461,6161
RANDAL KAUFMAN PHD PROGRAM DIRECTOR50 $388,639$0$64,168 $452,8071
LOUIS COFFMAN CAO & CFO50 $390,278$0$55,788 $446,0663
ZE'EV RONAI PHD PROGRAM DIRECTOR50 $354,747$0$68,113 $422,8602
ANNA BARKER PHD TRUSTEE1 $0$0$0 $01
DAN EPSTEIN TRUSTEE1 $0$0$0 $02
DAVID DOWN TRUSTEE1 $0$0$0 $08
DAVID SZEKERES TRUSTEE1 $0$0$0 $01
DONALD KERNS PHD TRUSTEE1 $0$0$0 $01
DOUGLAS OBENSHAIN TRUSTEE1 $0$0$0 $01
HENRY NORDOFF TRUSTEE1 $0$0$0 $01
JAMES BLAIR PHD CHAIRMAN1 $0$0$0 $01
JAMES JARDON TRUSTEE1 $0$0$0 $01
JAMES MYERS TRUSTEE1 $0$0$0 $01
KAREN HAYNES PHD TRUSTEE1 $0$0$0 $04
KATHERINE CHAPIN TRUSTEE (PART YEAR)1 $0$0$0 $01
KAZUMI SHIOSAKI PHD TRUSTEE1 $0$0$0 $01
MATTHEW BROWNE TRUSTEE1 $0$0$0 $01
PETER SEIDLER TRUSTEE (PART YEAR)1 $0$0$0 $01
STUART TANZ TRUSTEE1 $0$0$0 $01
WILLIAM GERHART VICE CHAIRMAN1 $0$0$0 $01
WILLIAM ROPER TRUSTEE1 $0$0$0 $01
KNOX BELL CORPORATE SECRETARY2 $0$0$0 $02
2019 · 26 people listed · 7 paid, $4.3M · 779 employees · 19 volunteers
NameTitleHrs/wkFrom orgFrom relatedOtherTotalOrgs
KRISTIINA VUORI MD PHD PRESIDENT50 $1,022,617$0$350,424 $1,373,0413
GARTH POWIS PHD CENTER DIRECTOR50 $504,532$0$53,042 $557,5741
MICHAEL JACKSON PHD DRUG DISCOVERY & DEV, SR VP50 $432,356$0$58,766 $491,1221
CARL WARE PHD CENTER DIRECTOR, IIDC50 $437,966$0$52,965 $490,9311
JORGE MOSCAT PHD PROGRAM DIRECTOR50 $431,058$0$55,855 $486,9131
LOUIS COFFMAN CAO & CFO50 $434,723$0$40,656 $475,3793
ZE'EV RONAI PHD PROGRAM DIRECTOR50 $383,277$0$65,401 $448,6782
DOUGLAS OBENSHAIN TRUSTEE1 $0$0$0 $01
DAVID DOWN TRUSTEE1 $0$0$0 $08
WILLIAM GERHART VICE CHAIRMAN1 $0$0$0 $01
STUART TANZ TRUSTEE1 $0$0$0 $01
JAMES JARDON TRUSTEE1 $0$0$0 $01
JAMES MYERS TRUSTEE1 $0$0$0 $01
KAZUMI SHIOSAKI PHD TRUSTEE1 $0$0$0 $01
PETER SEIDLER TRUSTEE (PART YEAR)1 $0$0$0 $01
DAN EPSTEIN TRUSTEE1 $0$0$0 $02
WILLIAM ROPER TRUSTEE1 $0$0$0 $01
MATTHEW BROWNE TRUSTEE1 $0$0$0 $01
DAVID SZEKERES TRUSTEE1 $0$0$0 $01
KAREN HAYNES PHD TRUSTEE1 $0$0$0 $04
DONALD KERNS PHD TRUSTEE1 $0$0$0 $01
JEANNE HERBERGER TRUSTEE (PART YEAR)1 $0$0$0 $01
ANNA BARKER PHD TRUSTEE1 $0$0$0 $01
HENRY NORDOFF TRUSTEE1 $0$0$0 $01
JAMES BLAIR PHD CHAIRMAN1 $0$0$0 $01
KNOX BELL CORPORATE SECRETARY2 $0$0$0 $02
2018 · 28 people listed · 9 paid, $4.9M · 911 employees · 19 volunteers
NameTitleHrs/wkFrom orgFrom relatedOtherTotalOrgs
KRISTIINA VUORI MD PHD PRESIDENT50 $1,010,709$0$345,320 $1,356,0293
PERRY NISEN FORMER CEO50 $780,458$0$0 $780,4581
GARTH POWIS PHD CENTER DIRECTOR50 $504,465$0$47,628 $552,0931
MICHAEL JACKSON PHD DRUG DISCOVERY & DEV, SR VP50 $439,813$0$58,021 $497,8341
CARL WARE PHD CENTER DIRECTOR, IIDC50 $404,789$0$47,395 $452,1841
RANDAL KAUFMAN PHD PROGRAM DIRECTOR50 $360,737$0$58,331 $419,0681
JORGE MOSCAT PHD PROGRAM DIRECTOR50 $350,276$0$57,743 $408,0191
GARY CHESSUM CFO (THRU 7/31/2018)50 $218,557$0$30,716 $249,2731
LOUIS COFFMAN CAO & CFO50 $207,752$0$23,657 $231,4093
DOUGLAS OBENSHAIN TRUSTEE1 $0$0$0 $01
DAVID DOWN TRUSTEE1 $0$0$0 $08
WILLIAM GERHART VICE CHAIRMAN1 $0$0$0 $01
ALAN GLEICHER TRUSTEE (PART YEAR)1 $0$0$0 $01
JEANNE HERBERGER TRUSTEE1 $0$0$0 $01
STUART TANZ TRUSTEE1 $0$0$0 $01
JAMES JARDON TRUSTEE1 $0$0$0 $01
DONALD ROSENBERG TRUSTEE (PART YEAR)1 $0$0$0 $01
JAMES MYERS TRUSTEE1 $0$0$0 $01
KAZUMI SHIOSAKI TRUSTEE1 $0$0$0 $01
PETER SEIDLER TRUSTEE1 $0$0$0 $01
ANNA BARKER TRUSTEE1 $0$0$0 $01
DANIEL EPSTEIN TRUSTEE1 $0$0$0 $01
HENRY NORDOFF TRUSTEE1 $0$0$0 $01
JAMES BLAIR CHAIR1 $0$0$0 $01
WILLIAM ROPER TRUSTEE1 $0$0$0 $01
MATTHEW BROWNE TRUSTEE1 $0$0$0 $01
DAVID SZEKERED TRUSTEE1 $0$0$0 $01
KNOX BELL CORPORATE SECRETARY2 $0$0$0 $02
2017 · 31 people listed · 8 paid, $5.3M · 969 employees · 22 volunteers
NameTitleHrs/wkFrom orgFrom relatedOtherTotalOrgs
KRISTIINA VUORI MD PHD PRESIDENT50 $969,097$0$343,074 $1,312,1713
PERRY NISEN MD PHD CEO (PART YEAR)50 $1,205,646$0-$431,901 $773,7451
EDWARD LEWANDOWSKI PROFESSOR50 $652,124$0$53,856 $705,9801
DANIEL KELLY MD CENTER DIR/SCI DIR AT LK NONA50 $602,402$0$44,466 $646,8681
GARTH POWIS PHD CENTER DIRECTOR50 $504,423$0$44,881 $549,3041
MICHAEL JACKSON PHD DRUG DISCOVERY & DEV, SR VP50 $388,597$0$54,059 $442,6561
CARL WARE PHD CENTER DIRECTOR, IIDC50 $393,349$0$44,954 $438,3031
GARY CHESSUM CFO50 $376,444$0$54,366 $430,8101
DOUGLAS OBENSHAIN TRUSTEE1 $0$0$0 $01
DAVID DOWN TRUSTEE1 $0$0$0 $08
WILLIAM GERHART TRUSTEE1 $0$0$0 $01
LUDER WHITLOCK TRUSTEE (PART YEAR)1 $0$0$0 $01
LORENZO BERHO TRUSTEE (PART YEAR)1 $0$0$0 $01
WAINWRIGHT FISHBURN TRUSTEE (PART YEAR)1 $0$0$0 $02
ALAN GLEICHER TRUSTEE1 $0$0$0 $01
JEANNE HERBERGER TRUSTEE1 $0$0$0 $01
DONALD JERNIGAN TRUSTEE (PART YEAR)1 $0$0$0 $01
EDWARD SCHULAK TRUSTEE (PART YEAR)1 $0$0$0 $01
STUART TANZ TRUSTEE1 $0$0$0 $01
CAROL GALLAGHER TRUSTEE (PART YEAR)1 $0$0$0 $03
GREG LUCIER TRUSTEE (PART YEAR)1 $0$0$0 $02
JAMES JARDON TRUSTEE1 $0$0$0 $01
DONALD ROSENBERG TRUSTEE1 $0$0$0 $01
JAMES MYERS TRUSTEE1 $0$0$0 $01
KAZUMI SHIOSAKI TRUSTEE1 $0$0$0 $01
PETER SEIDLER TRUSTEE1 $0$0$0 $01
ANNA BARKER TRUSTEE1 $0$0$0 $01
DANIEL EPSTEIN TRUSTEE1 $0$0$0 $01
HENRY NORDOFF CHAIRMAN1 $0$0$0 $01
JAMES BLAIR VICE CHAIRMAN1 $0$0$0 $01
KNOX BELL CORPORATE SECRETARY2 $0$0$0 $02
2016 · 35 people listed · 9 paid, $6.1M · 983 employees · 25 volunteers
NameTitleHrs/wkFrom orgFrom relatedOtherTotalOrgs
KRISTIINA VUORI MD PHD PRESIDENT50 $886,682$0$565,924 $1,452,6063
PERRY NISEN MD PHD CEO50 $1,115,133$0$122,179 $1,237,3121
DANIEL KELLY MD CNTR DIR/SCI DIR AT LK NONA50 $502,023$0$50,731 $552,7541
GARTH POWIS PHD CENTER DIRECTOR50 $503,978$0$42,359 $546,3371
EDWARD LEWANDOWSKI PROFESSOR50 $518,581$0$23,914 $542,4951
MICHAEL JACKSON PHD DRUG DISCOVERY & DEV, SR VP50 $433,071$0$50,455 $483,5261
CARL WARE PHD CENTER DIRECTOR, IIDC50 $417,535$0$42,616 $460,1511
GARY CHESSUM CFO50 $418,910$0$36,262 $455,1721
GARY RAISL ED D FORMER EVP/CAO/CFP/TREASURER0 $365,372$0$0 $365,3721
DOUGLAS OBENSHAIN TRUSTEE1 $0$0$0 $01
BERNARD MACHEN TRUSTEE (PART YEAR)1 $0$0$0 $01
DAVID DOWN TRUSTEE1 $0$0$0 $08
WILLIAM GERHART TRUSTEE1 $0$0$0 $01
RASESH THAKKAR TRUSTEE (PART YEAR)1 $0$0$0 $01
LUDER WHITLOCK TRUSTEE1 $0$0$0 $01
LORENZO BERHO TRUSTEE1 $0$0$0 $01
DANIEL EPSTEIN TRUSTEE1 $0$0$0 $01
WAINWRIGHT FISHBURN TRUSTEE1 $0$0$0 $02
PATRICK GERAGHTY TRUSTEE (PART YEAR)1 $0$0$0 $01
ALAN GLEICHER TRUSTEE1 $0$0$0 $01
JEANNE HERBERGER TRUSTEE1 $0$0$0 $01
DONALD JERNIGAN TRUSTEE1 $0$0$0 $01
DOUG MANCHESTER TRUSTEE (PART YEAR)1 $0$0$0 $01
EDWARD SCHULAK TRUSTEE1 $0$0$0 $01
STUART TANZ TRUSTEE1 $0$0$0 $01
CAROL GALLAGHER TRUSTEE1 $0$0$0 $03
GREG LUCIER TRUSTEE1 $0$0$0 $02
JAMES JARDON TRUSTEE1 $0$0$0 $01
DONALD ROSENBERG TRUSTEE1 $0$0$0 $01
JAMES MYERS TRUSTEE1 $0$0$0 $01
KAZUMI SHIOSAKI TRUSTEE1 $0$0$0 $01
HENRY NORDOFF CHAIRMAN1 $0$0$0 $01
JAMES BLAIR VICE CHAIR1 $0$0$0 $01
PAULINE FOSTER TRUSTEE (PART YEAR)1 $0$0$0 $01
KNOX BELL CORPORATE SECRETARY2 $0$0$0 $02
2015 · 31 people listed · 9 paid, $7.6M · 1,015 employees · 22 volunteers
NameTitleHrs/wkFrom orgFrom relatedOtherTotalOrgs
KRISTIINA VUORI MD PHD PRESIDENT50 $2,666,889$0$112,645 $2,779,5343
PERRY NISEN MD PHD CEO50 $1,111,930$0$336,252 $1,448,1821
GARTH POWIS PHD CENTER DIRECTOR50 $548,622$0$37,785 $586,4071
DANIEL KELLY MD CNTR DIR/SCI DIR AT LK NONA50 $537,617$0$45,718 $583,3351
MICHAEL JACKSON PHD DRUG DISCOVERY & DEV, SR VP50 $456,626$0$43,695 $500,3211
GARY RAISL ED D EVP/CAO/CFO/TREAS (OUTGOING)50 $463,475$0$34,830 $498,3051
CARL WARE PHD CENTER DIRECTOR, IIDC50 $439,854$0$39,071 $478,9251
ZE'EV RONAI SCIENTIFIC DIRECTOR50 $333,540$0$44,002 $377,5422
GARY CHESSUM CFO50 $325,857$0$5,855 $331,7121
DAVID DOWN TRUSTEE1 $0$0$0 $08
WILLIAM GERHART TRUSTEE1 $0$0$0 $01
RASESH THAKKAR TRUSTEE1 $0$0$0 $01
LUDER WHITLOCK TRUSTEE1 $0$0$0 $01
LORENZO BERHO TRUSTEE1 $0$0$0 $01
JAMES BLAIR VICE CHAIRMAN1 $0$0$0 $01
DANIEL EPSTEIN TRUSTEE1 $0$0$0 $01
WAINWRIGHT FISHBURN TRUSTEE1 $0$0$0 $02
PAULINE FOSTER TRUSTEE1 $0$0$0 $01
PATRICK GERAGHTY TRUSTEE1 $0$0$0 $01
ALAN GLEICHER TRUSTEE1 $0$0$0 $01
JEANNE HERBERGER TRUSTEE1 $0$0$0 $01
DONALD JERNIGAN TRUSTEE1 $0$0$0 $01
DOUG MANCHESTER TRUSTEE1 $0$0$0 $01
EDWARD SCHULAK TRUSTEE1 $0$0$0 $01
STUART TANZ TRUSTEE1 $0$0$0 $01
CAROL GALLAGHER TRUSTEE1 $0$0$0 $03
GREG LUCIER TRUSTEE1 $0$0$0 $02
HENRY NORDOFF TRUSTEE1 $0$0$0 $01
DOUGLAS OBENSHAIN TRUSTEE1 $0$0$0 $01
BERNARD MACHEN CHAIRMAN1 $0$0$0 $01
KNOX BELL SECRETARY2 $0$0$0 $02
2014 · 34 people listed · 8 paid, $5.1M · 1,000 employees · 20 volunteers
NameTitleHrs/wkFrom orgFrom relatedOtherTotalOrgs
KRISTIINA VUORI MD PHD INTERIM CEO/PRESIDENT50 $1,124,006$0$336,919 $1,460,9253
PERRY NISEN MD PHD CEO50 $563,569$0$204,422 $767,9911
GARTH POWIS PHD CENTER DIRECTOR50 $501,420$0$41,055 $542,4751
DANIEL KELLY MD CNTR DIR/SCI DIR AT LK NONA50 $475,364$0$47,712 $523,0761
STUART LIPTON MD PHD CENTER DIRECTOR50 $455,233$0$50,591 $505,8241
GARY RAISL ED D EVP/CAO/CFO/TREASURER50 $439,576$0$42,613 $482,1891
CARL WARE PHD CENTER DIRECTOR, IIDC50 $359,036$0$39,136 $398,1721
MICHAEL JACKSON PHD DRUG DISCOVERY & DEV, SR VP50 $354,616$0$42,915 $397,5311
DAVID DOWN TRUSTEE1 $0$0$0 $08
WILLIAM GERHART TRUSTEE1 $0$0$0 $01
RASESH THAKKAR TRUSTEE1 $0$0$0 $01
LUDER WHITLOCK TRUSTEE1 $0$0$0 $01
LORENZO BERHO TRUSTEE1 $0$0$0 $01
JAMES BLAIR TRUSTEE1 $0$0$0 $01
DANIEL EPSTEIN TRUSTEE1 $0$0$0 $01
WAINWRIGHT FISHBURN TRUSTEE1 $0$0$0 $02
PAULINE FOSTER TRUSTEE1 $0$0$0 $01
PATRICK GERAGHTY TRUSTEE1 $0$0$0 $01
ALAN GLEICHER TRUSTEE1 $0$0$0 $01
JEANNE HERBERGER TRUSTEE1 $0$0$0 $01
DONALD JERNIGAN TRUSTEE1 $0$0$0 $01
PAPA DOUG MANCHESTER TRUSTEE1 $0$0$0 $01
EDWARD SCHULAK TRUSTEE1 $0$0$0 $01
GREG LUCIER CHAIRMAN1 $0$0$0 $02
HENRY NORDOFF TRUSTEE1 $0$0$0 $01
DOUGLAS OBENSHAIN TRUSTEE1 $0$0$0 $01
BERNARD MACHEN TRUSTEE1 $0$0$0 $01
BRENT JACOBS TRUSTEE (PART YEAR)1 $0$0$0 $02
JAMES JARDON TRUSTEE (PART YEAR)1 $0$0$0 $01
PETER PREUSS TRUSTEE (PART YEAR)1 $0$0$0 $05
ANDREW VITERBI TRUSTEE (PART YEAR)1 $0$0$0 $02
ALLEN WEISS TRUSTEE (PART YEAR)1 $0$0$0 $01
GAYLE WILSON TRUSTEE (PART YEAR)1 $0$0$0 $01
KNOX BELL SECRETARY2 $0$0$0 $02
2013 · 32 people listed · 9 paid, $2.9M · 1,067 employees · 23 volunteers
NameTitleHrs/wkFrom orgFrom relatedOtherTotalOrgs
KRISTIINA VUORI MD PHD INTERIM CEO/PRESIDENT50 $639,237$0$337,141 $976,3783
STUART LIPTON MD PHD CENTER DIRECTOR50 $466,329$0$67,015 $533,3441
DANIEL KELLY MD CNTR DIR./SCI. DIR. AT LK NONA50 $474,889$0$53,514 $528,4031
GARY F RAISL EDD EVP/CAO/CFO/TREASURER50 $450,474$0$57,267 $507,7411
CARL WARE PHD CENTER DIRECTOR, IIDC50 $362,037$0$48,727 $410,7641
JORGE MOSCAT PHD PROGRAM DIRECTOR50 $319,251$0$45,900 $365,1511
DWIGHT TOWLER PROGRAM DIRECTOR50 $329,949$0$20,810 $350,7591
MARGARET DUNBAR JD SECRETARY/SR DIRECTOR IP50 $172,290$0$17,562 $189,8521
BRENT JACOBS TRUSTEE1 --- $02
JAMES JARDON TRUSTEE1 --- $01
BERNARD MACHEN TRUSTEE1 --- $01
HENRY NORDOFF TRUSTEE1 --- $01
DOUGLAS OBENSHAIN TRUSTEE1 --- $01
PETER PREUSS TRUSTEE1 --- $05
ANDREW VITERBI TRUSTEE1 --- $02
ALLEN WEISS TRUSTEE1 --- $01
GAYLE WILSON TRUSTEE1 --- $01
GREG LUCIER TRUSTEE/CHAIRMAN1 $0$0$0 $02
DAVID DOWN TRUSTEE1 $0$0$0 $08
WILLIAM GERHART TRUSTEE1 $0$0$0 $01
RASESH THAKKAR TRUSTEE1 $0$0$0 $01
LUDER WHITLOCK TRUSTEE1 $0$0$0 $01
LORENZO BERHO TRUSTEE1 --- $01
JAMES BLAIR TRUSTEE1 --- $01
SHEHAN DISSANAYAKE TRUSTEE1 --- $01
DANIEL EPSTEIN TRUSTEE1 --- $01
WAINWRIGHT FISHBURN TRUSTEE/PART YEAR CHAIRMAN1 $0$0$0 $02
PAULINE FOSTER TRUSTEE1 --- $01
PATRICK GERAGHTY TRUSTEE1 --- $01
ALAN GLEICHER TRUSTEE1 --- $01
JEANNE HERBERGER TRUSTEE1 --- $01
JOHN C REED MD PHD FORMER CEO50 $404,882$0-$1,373,283 -$968,4012
2012 · 31 people listed · 9 paid, $4.7M · 1,130 employees · 22 volunteers
NameTitleHrs/wkFrom orgFrom relatedOtherTotalOrgs
JOHN C REED MD PHD CEO50 $680,710$0$400,613 $1,081,3232
KRISTIINA VUORI MD PHD PRESIDENT/INTERIM CEO50 $614,402$0$336,101 $950,5033
STUART LIPTON MD PHD CENTER DIRECTOR50 $448,146$0$52,739 $500,8851
DANIEL KELLY MD CNTR DIR./SCI. DIR. AT LK NONA50 $446,021$0$50,001 $496,0221
GARY F RAISL EDD EVP/CAO/CFO/TREASURER50 $432,812$0$48,941 $481,7531
CARL WARE PHD CENTER DIRECTOR50 $347,871$0$34,808 $382,6791
CYRIL DOUCET VP, ADMIN. AT LAKE NONA50 $307,670$0$35,312 $342,9821
JORGE MOSCAT PHD PROGRAM DIRECTOR50 $279,856$0$45,878 $325,7341
MARGARET DUNBAR JD SECRETARY/SR DIRECTOR IP50 $165,701$0$15,321 $181,0221
LORENZO BERHO TRUSTEE1 $0$0$0 $01
JAMES BLAIR TRUSTEE1 $0$0$0 $01
SHEHAN DISSANAYAKE TRUSTEE1 $0$0$0 $01
DANIEL EPSTEIN TRUSTEE1 $0$0$0 $01
WAIN FISHBURN TRUSTEE/CHAIRMAN1 $0$0$0 $02
PAULINE FOSTER TRUSTEE1 $0$0$0 $01
PATRICK GERAGHTY TRUSTEE1 $0$0$0 $01
ALAN GLEICHER TRUSTEE1 $0$0$0 $01
JEANNE HERBERGER TRUSTEE1 $0$0$0 $01
BRENT JACOBS TRUSTEE1 $0$0$0 $02
JAMES JARDON TRUSTEE1 $0$0$0 $01
ROBERT LAUER TRUSTEE1 $0$0$0 $01
BERNARD MACHEN TRUSTEE1 $0$0$0 $01
NICOLAS NIERENBERG TRUSTEE1 $0$0$0 $01
HENRY NORDOFF TRUSTEE1 $0$0$0 $01
DOUGLAS OBENSHAIN TRUSTEE1 $0$0$0 $01
PETER PREUSS TRUSTEE1 $0$0$0 $05
DUANE ROTH TRUSTEE1 $0$0$0 $05
JAN TUTTLEMAN TRUSTEE1 $0$0$0 $01
ANDREW VITERBI TRUSTEE1 $0$0$0 $02
ALLEN WEISS TRUSTEE1 $0$0$0 $01
GAYLE WILSON TRUSTEE1 $0$0$0 $01
2011 · 36 people listed · 11 paid, $6.2M · 1,157 employees · 25 volunteers
NameTitleHrs/wkFrom orgFrom relatedOtherTotalOrgs
JOHN C REED MD PHD CEO50 $942,673$0$427,253 $1,369,9262
KRISTIINA VUORI MD PHD PRESIDENT50 $757,003$0$345,887 $1,102,8903
GARY F RAISL EDD EVP/CAO/CFO/TREASURER50 $511,225$0$50,559 $561,7841
DANIEL KELLY MD SCIENTIFIC DIRECTOR50 $487,867$0$50,968 $538,8351
PAUL LAIKIND PHD SR VP CBO50 $468,434$0$59,835 $528,2693
STUART LIPTON MD PHD CENTER DIRECTOR50 $464,312$0$58,415 $522,7271
CARL WARE PHD CENTER DIRECTOR50 $359,943$0$49,600 $409,5431
EDGAR GILLENWATERS VP EXTERNAL RELATIONS50 $272,625$0$63,366 $335,9911
TARIQ RANA PHD PROGRAM DIRECTOR50 $281,338$0$45,966 $327,3041
JORGE MOSCAT PHD PROFESSOR50 $282,768$0$36,499 $319,2671
MARGARET DUNBAR JD SECRETARY/SR DIRECTOR IP50 $172,085$0$20,302 $192,3871
LORENZO BERHO TRUSTEE1 $0$0$0 $01
ARTHUR BRODY TRUSTEE1 $0$0$0 $01
SHEHAN DISSANAYAKE TRUSTEE1 $0$0$0 $01
DANIEL EPSTEIN TRUSTEE1 $0$0$0 $01
WAIN FISHBURN TRUSTEE/CHAIRMAN1 $0$0$0 $02
PAULINE FOSTER TRUSTEE1 $0$0$0 $01
ALAN GLEICHER TRUSTEE1 $0$0$0 $01
DAVID HALE TRUSTEE1 $0$0$0 $011
JEANNE HERBERGER TRUSTEE1 $0$0$0 $01
BRENT JACOBS TRUSTEE1 $0$0$0 $02
JAMES JARDON TRUSTEE1 $0$0$0 $01
ROBERT LAUER TRUSTEE1 $0$0$0 $01
GREG LUCIER TRUSTEE1 $0$0$0 $02
ROBERT MANDELL TRUSTEE1 $0$0$0 $01
NICOLAS NIERENBERG TRUSTEE1 $0$0$0 $01
DOUGLAS OBENSHAIN TRUSTEE1 $0$0$0 $01
PETER PREUSS TRUSTEE1 $0$0$0 $05
DUANNE ROTH TRUSTEE1 $0$0$0 $01
STUART TANZ TRUSTEE1 $0$0$0 $01
JAN TUTTLEMAN TRUSTEE1 $0$0$0 $01
ANDREW VITERBI TRUSTEE1 $0$0$0 $02
BARBARA WARREN TRUSTEE1 $0$0$0 $01
ALLEN WEISS TRUSTEE1 $0$0$0 $01
GAYLE WILSON TRUSTEE1 $0$0$0 $01
DIANE WINOKUR TRUSTEE1 $0$0$0 $01
2010 · 38 people listed · 10 paid, $5.7M · 1,184 employees · 28 volunteers
NameTitleHrs/wkFrom orgFrom relatedOtherTotalOrgs
JOHN C REED MD PHD CEO50 $947,875$0$528,531 $1,476,4062
KRISTIINA VUORI MD PHD PRESIDENT/DIRECTOR, CANCER CEN50 $649,105$0$362,648 $1,011,7533
GARY F RAISL EDD EXECUTIVE VP/CAO/CFO/TREASURER50 $486,871$0$111,509 $598,3801
DANIEL KELLY MD CENTER DIRECTOR50 $493,345$0$88,948 $582,2931
STUART LIPTON MD PHD CENTER DIRECTOR50 $473,197$0$74,537 $547,7341
PAUL LAIKIND SR VP, CHIEF BUSINESS OFFICER50 $299,606$0$87,185 $386,7913
BLAIR BLUM SR VP, EXTERNAL RELATIONS50 $319,402$0$44,392 $363,7941
EDGAR GILLENWATERS VP, EXTERNAL RELATIONS50 $282,683$0$75,038 $357,7211
FRED LEVINE MD PHD TRUSTEE/CENTER DIRECTOR50 $213,660$0$30,835 $244,4951
CARL WARE PHD TRUSTEE/CENTER DIRECTOR50 $142,271$0$24,287 $166,5581
BRIDGETTE BREN TRUSTEE1 $0$0$0 $01
ARTHUR BRODY TRUSTEE1 $0$0$0 $01
MALIN BURNHAM TRUSTEE1 $0$0$0 $015
SHEHAN DISSANYAKE TRUSTEE1 $0$0$0 $01
WAIN FISHBURN TRUSTEE1 $0$0$0 $02
JEANNIE FONTANA TRUSTEE1 $0$0$0 $01
PAULINE FOSTER TRUSTEE1 $0$0$0 $01
ALAN GLEICHER TRUSTEE1 $0$0$0 $01
DAVID HALE TRUSTEE1 $0$0$0 $011
JEANNE HERBERGER TRUSTEE1 $0$0$0 $01
BRENT JACOBS TRUSTEE1 $0$0$0 $02
JIM JARDON TRUSTEE1 $0$0$0 $01
ROBERT LAUER TRUSTEE1 $0$0$0 $01
SHEILA LIPINSKY TRUSTEE1 $0$0$0 $01
GREG LUCIER TRUSTEE/CHAIRMAN1 $0$0$0 $02
DOUGLAS MANCHESTER TRUSTEE1 $0$0$0 $01
ROBERT MANDELL TRUSTEE1 $0$0$0 $01
NICOLAS NIERENBERG TRUSTEE1 $0$0$0 $01
DOUGLAS OBENSHAIN TRUSTEE1 $0$0$0 $01
PETER PREUSS TRUSTEE1 $0$0$0 $05
STUART TANZ TRUSTEE1 $0$0$0 $01
JAN TUTTLEMAN TRUSTEE1 $0$0$0 $01
ANDREW VITERBI TRUSTEE1 $0$0$0 $02
BARBARA BOBBI WARREN TRUSTEE1 $0$0$0 $01
ALAN WEISS TRUSTEE1 $0$0$0 $01
GAYLE WILSON TRUSTEE1 $0$0$0 $01
DIANE WINOKUR TRUSTEE1 $0$0$0 $01
KEN WOOLCOTT TRUSTEE1 $0$0$0 $01

Highest-paid independent contractors

2024 · 5 contractors · $1.8M
NameLocationServicePaid
DELOITTE & TOUCHE LLPDALLAS, TXPROFESSIONAL SERVICES$433,527
1903 SOLUTIONS LLCNEWPORT BEACH, CANETWORKING, SECURITY, IT SERVICES$425,572
BIODURO LLCIRVINE, CABIOTECHNOLOGY SERVICES$404,003
UNIVERSAL PROTECTION SERVICE LPPASADENA, CABUILDING SECURITY SERVICES$286,557
JAGGAER LLCMORRISVILLE, NCPROCUREMENT SERVICES$233,784
2023 · 5 contractors · $1.3M
NameLocationServicePaid
Universal Protection Service LPPasadena, CABuilding Security Services$326,043
Wilson Sonsini Goodrich & RosatiLos Angeles, CALegal Services$310,415
Deloitte & Touche LLPDallas, TXProfessional Services$269,260
JAGGAER LLCDALLAS, TXProcurement Services$229,200
Constangy Brooks Smith & Porphete LLPAtlanta, GALegal Services$201,763
2022 · 5 contractors · $1.5M
NameLocationServicePaid
Universal Protection Service LPPasadena, CABuilding security services$374,203
Deloitte & Touche LLPDallas, TXAudit services$373,337
Wilson Sonsini Goodrich & RosatiLos Angeles, CALegal services$372,919
JAGGAER LLCDALLAS, TXDigital procurement services$224,706
Divigard & Associates LLCNorthampton, MAConsulting services$185,088
2021 · 5 contractors · $2.8M
NameLocationServicePaid
DPR ConstructionRedwood City, CAConstruction services$1,244,983
Wilson Sonsini Goodrich & RosatiLos Angeles, CALegal services$566,374
Universal Protection Service LPPasadena, CABuilding security services$370,711
Deloitte & Touche LLPDallas, TXAudit services$315,935
Rebecca JorgensonWaconia, MNBusiness Consulting Services$269,740
2020 · 5 contractors · $1.8M
NameLocationServicePaid
DPR CONSTRUCTIONREDWOOD CITY, CACONSTRUCTION SRVICES$666,044
WILSON SONSINI GOODRICHLOS ANGELES, CALEGAL SERVICES$377,383
DELOITTE TOUCHE LLPDALLAS, TXAUDIT SERVICES$303,117
CARY THOMASCARLSBAD, CACONSULTING$224,733
FITCH CONTRACTING COLAKESIDE, CACONSTRUCTION SRVICES$212,900
2019 · 5 contractors · $1.2M
NameLocationServicePaid
DELOITTE TOUCHE LLPSAN DIEGO, CAAUDIT SERVICES$384,891
WILSON SONSINI GOODRICHLOS ANGELES, CALEGAL SERVICES$258,150
STEALTH PARTNER GROUPSCOTTSDALE, AZADMIN SERVICES$190,745
DLA PIPER LLPBALTIMORE, MDLEGAL SERVICES$180,078
CLARIVATE ANALYTICS LLCCAROL STREAM, ILDATA CONSULTANTS$178,713
2018 · 5 contractors · $1.8M
NameLocationServicePaid
DLA Piper LLPBaltimore, MDLegal Services$647,033
Superion LLCChicago, ILSoftware Development$461,826
DELOITTE TOUCHE LLPSAN DIEGO, CAAUDIT SERVICES$287,648
Wilson Sonsini GoodrichLOS ANGELES, CALegal Services$249,527
Stealth Partner GroupScottsdale, AZAdmin Services$203,673
2017 · 5 contractors · $2.1M
NameLocationServicePaid
DLA PIPER US LLPSAN DIEGO, CALEGAL SERVICES$569,166
Adimab LLC partnershipLebanon, NHLab/Research SVCS$456,519
Allied Universal Security - PartnerPasadena, CASecurity Services$420,476
Deloitte Touche LLPSan Diego, CAAUDIT SERVICES$417,295
Wilson Sonsini GoodrichLos Angeles, CALEGAL SERVICES$248,000
2016 · 5 contractors · $1.2M
NameLocationServicePaid
DLA PIPER US LLPBaltimore, MDLegal SERVICES$634,757
Deloitte Touche LLPDALLAS, TXAudit SERVICES$191,957
Pabst Patent Group LLPAtlanta, GALegal SERVICES$140,269
Kenneth WidderRANCHO SANTA FE, CAConsulting SERVICES$118,350
Wilson Sonsini GoodrichLos Angeles, CALegal SERVICES$111,891
2015 · 5 contractors · $2.1M
NameLocationServicePaid
DELOITTE TOUCHE LLPSAN DIEGO, CAAUDIT AND CONSULTING$699,047
DLA PIPER US LLPBALTIMORE, MDLEGAL$496,299
ARMADA ADMINISTRATORSBALTIMORE, MDCONSULTING-INSURANCE$450,095
STEVEN K BRAUERSAN DIEGO, CACONSULTING-BUS. DEV.$245,245
BERMAN PROPERTY MANAGEMENTKISSIMMEE, FLPROPERTY MANAGEMENT$227,745
2014 · 5 contractors · $2.6M
NameLocationServicePaid
Deloitte Touche LLPSan Diego, CAAudit and Consulting$997,960
Four Oaks Partners ConsultingRancho Santa Fe, CAConsulting-strat pln$467,749
Dimensional Fund AdvisorSanta Monica, CAConsulting - inv adv$450,000
Steven K BrauerSan Diego, CAConsulting-Bus. dev.$445,620
DLA PiperBaltimore, MDLegal$277,352
2013 · 5 contractors · $1.3M
NameLocationServicePaid
DELOITTE TOUCHE LLPAUDIT$295,389
STEVEN K BRAUERConsulting Bus. Dev.$265,335
PABST PATENT GROUPLEGAL$262,506
DLA PIPERLEGAL$252,848
BERMAN PROPERTY MANAGEMENTJANITORIAL$227,916
2012 · 5 contractors · $1.7M
NameLocationServicePaid
Pabst Patent GroupATLANTA, GALEGAL$498,923
DLA Piper US LLPBALTIMORE, MDLEGAL$459,291
Deloitte ToucheSAN DIEGO, CAAUDIT$297,488
Berman Property ManagementORLANDO, FLJanitorial$215,592
Jones DaySAN DIEGO, CALegal$200,927
2011 · 5 contractors · $2.0M
NameLocationServicePaid
DLA PIPER US LLPBALTIMORE, MDLEGAL$665,449
PABST PATENT GROUPATLANTA, GALEGAL$588,922
JONES DAYSAN DIEGO, CALEGAL$309,882
DELOITTE TOUCHEORLANDO, FLAUDIT$243,384
BERMAN PROPERTY MANAGEMENT LLCORLANDO, FLJANITORIAL$237,363
2010 · 5 contractors · $1.9M
NameLocationServicePaid
ARNALL GOLDEN GREGORY LLPATLANTA, GALEGAL$674,221
DLA PIPER US LLPBALTIMORE, MDLEGAL$414,125
MCDERMOTT WILL EMERY LLPSAN DIEGO, CALEGAL$349,593
DELOITTE TOUCHE LLPORLANDO, FLAUDIT$318,077
BERMAN PROPERTY MANAGEMENT LLPORLANDO, FLJANITORIAL$186,789

Who gave

Contributor names are not public for this form type.

Public charities filing Form 990 or 990-EZ report large donors on Schedule B, but the IRS withholds their names and addresses from public copies. Private foundations (990-PF) are different: their contributors are public.

Finances

Newest first. Each filing: its name on one row, its figures on the row beneath. Greyed filings are superseded by a later return for the same period and are left out everywhere else on this page.

RevenueExpensesAssetsNet assetsContributionsProgram revenueOfficer payEmployeesVolunteers
2024 · Form 990 period ending 2025-06-30 · view filing · original 990 ↗
$114,401,821$116,107,616 $337,965,900$282,330,095 $100,911,209$781,895 $1,668,68961114
2023 · Form 990 period ending 2024-06-30 · view filing · original 990 ↗
$123,272,481$111,174,592 $326,353,986$268,211,594 $107,001,067$669,975 $1,465,15059416
2022 · Form 990 period ending 2023-06-30 · view filing · original 990 ↗
$117,219,104$103,397,718 $308,605,226$243,533,988 $104,423,511$1,012,265 $1,054,50962415
2021 · Form 990 period ending 2022-06-30 · view filing · original 990 ↗
$107,303,034$106,781,079 $289,830,509$219,630,000 $82,047,252$806,855 $2,080,33864515
2020 · Form 990 period ending 2021-06-30 · view filing · original 990 ↗
$124,726,984$108,924,075 $337,147,969$260,710,870 $111,444,313$853,344 $2,404,48969619
2019 · Form 990 period ending 2020-06-30 · view filing · original 990 ↗
$116,730,403$112,647,929 $307,274,683$214,124,442 $100,963,692$643,286 $1,732,08677919
2018 · Form 990 period ending 2019-06-30 · view filing · original 990 ↗
$122,956,459$186,280,858 $338,796,799$215,607,420 $108,300,329$799,803 $1,240,16791119
2017 · Form 990 period ending 2018-06-30 · view filing · original 990 ↗
$125,326,751$143,519,364 $430,760,547$281,665,303 $113,630,164$1,300,446 $2,696,93196922
2016 · Form 990 period ending 2017-06-30 · view filing · original 990 ↗
$134,174,165$146,845,314 $482,051,570$307,188,980 $121,777,889$1,413,894 $2,391,38398325
2015 · Form 990 period ending 2016-06-30 · view filing · original 990 ↗
$129,105,071$142,368,594 $517,058,113$309,195,651 $112,687,922$1,984,033 $3,584,7031,01522
2014 · Form 990 period ending 2015-06-30 · view filing · original 990 ↗
$255,146,810$151,893,967 $427,646,063$332,331,211 $244,026,040$906,508 $3,011,4211,00020
2013 · Form 990 period ending 2014-06-30 · view filing · original 990 ↗
$153,868,003$142,659,251 $339,669,216$231,707,004 $146,698,221$1,097,834 $2,287,1731,06723
2012 · Form 990 period ending 2013-06-30 · view filing · original 990 ↗
$152,710,196$148,976,090 $315,253,706$215,038,217 $146,497,371$1,077,105 $1,841,6991,13022
2011 · Form 990 period ending 2012-06-30 · view filing · original 990 ↗
$162,097,035$158,377,766 $316,383,458$207,224,221 $156,880,684$774,874 $3,820,6751,15725
2010 · Form 990 period ending 2011-06-30 · view filing · original 990 ↗
$162,686,057$161,165,052 $321,579,555$206,490,814 $160,093,433$0 $3,501,4651,18428

Connected to

Organizations that list some of the same people on their returns (officers, directors, key employees on this organization’s latest return), and related organizations it lists on Schedule R.

Funders of this organization

114 grantors reported grants to this organization, $97,252,976 in all, tax years 2009 to 2025; the 25 largest shown (all 114). Exact: the grantor wrote this organization's EIN. Fuzzy: the grantor wrote only a name (foundations' 990-PF has no EIN field), matched to the same or a near-identical name in the same state; the name as filed is shown. From the latest return for each grantor and year, so amended returns aren't counted twice. CSV

GrantorTotal givenGrantsLatest year's amountLatest yearYears givenTypeMatchGrants
SANFORD $9,000,0003 $1,000,0002012 2010-2012 Public charity Exact
show
MAYO CLINIC $6,555,59412 $179,1802024 2013-2024 DAF sponsor Exact
show
MAYO CLINIC GROUP RETURN $5,880,1828 $781,0272024 2017-2024 Public charity Exact
show
AMERICAN CANCER SOCIETY INC $5,567,6137 $300,0002023 2010, 2017, 2019-2023 Public charity Exact
show
AMERICAN HEART ASSOCIATION INC $5,233,63411 $63,0402020 2010-2020 Public charity Exact
show
YALE UNIVERSITY $4,666,5308 $277,8842024 2009-2015, 2024 DAF sponsor Exact
show
CUREBOUND INC $4,585,84512 $1,529,5482025 2013-2019, 2021-2025 Public charity Exact
show
WASHINGTON UNIVERSITY $4,094,44112 $282,0372024 2012-2016, 2018-2024 DAF sponsor Exact
show
SANFORD $4,000,0001 $4,000,0002009 2009 Public charity Exact
show
UNIVERSITY OF MIAMI $2,643,15110 $155,3492021 2011-2014, 2016-2021 Public charity Exact
show
NORTHWESTERN UNIVERSITY $2,569,6199 $92,8062018 2010-2018 DAF sponsor Exact
show
DONOR ADVISED CHARITABLE GIVING $2,188,66212 $537,0002024 2014-2024 DAF sponsor Exact
show
SCRIPPS RESEARCH INSTITUTE $2,057,5924 $572,7622024 2021-2024 Public charity Exact
show
THE V FOUNDATION $1,900,0005 $600,0002024 2015, 2017-2018, 2021, 2024 Public charity Exact
show
DANA-FARBER CANCER INSTITUTE $1,895,8954 $311,1202012 2009-2012 Public charity Exact
show
MICHAEL J FOX FOUNDATION FOR PARKINSONS RESEARCH $1,883,5194 $49,0002018 2010, 2012, 2014, 2018 Public charity Exact
show
BILL & DINAH RUCH FAMILY FOUNDATION $1,780,0005 $500,0002025 2018, 2022-2025 Private foundation Fuzzy filed as “SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE”
show
BREAKTHROUGH T1D $1,651,3496 $330,0002023 2009, 2014-2015, 2021-2023 Public charity Exact
show
MUSCULAR DYSTROPHY ASSOCIATION $1,625,32814 $31,5002025 2010-2013, 2015-2019, 2022-2025 Public charity Exact
show
THE SAN DIEGO FOUNDATION $1,454,8348 $37,5002024 2011-2012, 2014, 2016-2018, 2023-2024 DAF sponsor Exact
show
SUSAN G KOMEN BREAST CANCER FOUNDATION $1,432,70210 $49,9942022 2010-2013, 2015, 2018-2020, 2022 Public charity Exact
show
American Diabetes Association Research Foundation Inc $1,287,88512 $217,5002016 2010, 2012-2016 Public charity Exact
show
THE MEDICAL COLLEGE OF WISCONSIN INC $1,267,5002 $746,0242024 2023-2024 Public charity Exact
show
BROAD INSTITUTE INC $1,142,7787 $83,6952020 2011-2013, 2017-2020 Public charity Exact
show
JEWISH COMMUNITY FOUNDATION OF SAN DIEGO $1,136,20515 $18,4802024 2010-2024 DAF sponsor Exact
show

Nearby + Similar BETA

Organizations like this one: what they do and who they are linked to

Same category: NTEE code and revenue

Ranked without any AI: same NTEE code first, then the same NTEE group; then revenue within 2x, 5x or 10x; then the same state; then similar name and mission text. NTEE: the IRS’s code when it lists one, otherwise FURP’s inferred code. Same state only · More (100)

OrganizationStateNTEELatest revenueLatest expensesTop-paid titleTop payWhy similar
STOWERS INSTITUTE FOR MEDICAL RESEARCHMOH92 $102,011,512$104,688,153 DIRECTOR/CHAIR DECEASED 3/27/25$3,206,337 Same NTEE code H92, revenue within 2x, similar mission
LOVELACE BIOMEDICAL RESEARCH INSTITUTENMH92 $83,397,041$87,744,696 PRESIDENT AND CHAIRMAN OF THE BOARD$1,387,128 Same NTEE code H92, revenue within 2x, similar mission
WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCHMAH92 $222,267,487$174,270,117 DIRECTOR/PRESIDENT$1,081,921 Same NTEE code H92, revenue within 2x
FOUNDATION FOR THE NATIONAL INSTITUTE OF HEALTH INCMDH92 $78,507,209$76,818,918 Chief Executive Officer$689,835 Same NTEE code H92, revenue within 2x, similar mission
BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASONWAH92 $81,277,408$80,732,627 CHIEF EXECUTIVE OFFICER VMFH$5,754,859 Same NTEE code H92, revenue within 2x
OKLAHOMA MEDICAL RESEARCH FOUNDATIONOKH92 $136,776,829$126,476,987 EVP and Chief Medical Officer$1,016,574 Same NTEE code H92, revenue within 2x
GARY AND MARY WEST HEALTH INSTITUTECAH92 $44,564,569$42,453,440 CMO & EVP CLINICAL RESEARCH$958,995 Same NTEE code H92, revenue within 5x, same state
SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCHWAH92 $25,335,790$25,203,489 DIRECTOR$386,696 Same NTEE code H92, revenue within 5x
BIOMEDICAL RESEARCH FOUNDATION OF NORTHWEST LOUISIANALAH92 $25,307,433$20,561,945 CEO/PRESIDENT$814,733 Same NTEE code H92, revenue within 5x
SCRIPPS RESEARCH INSTITUTECAH92 $698,624,318$537,453,981 PRESIDENT/CEO$1,859,240 Same NTEE code H92, revenue within 10x, same state
STEADMAN PHILIPPON RESEARCH INSTITUTECOH92 $14,151,760$16,201,121 CHIEF SCIENTIFIC OFFICER$661,826 Same NTEE code H92, revenue within 10x
JACKSON LABORATORYMEH92 $652,542,607$617,013,316 PRESIDENT & CEO$2,746,750 Same NTEE code H92, revenue within 10x
WASHINGTON RESEARCH FOUNDATIONWAH92 $13,350,694$23,039,321 PRESIDENT & CEO$793,167 Same NTEE code H92, revenue within 10x
APPLIED BIOMEDICAL SCIENCE INSTITUTECAH92 $4,539,463$4,281,826 PROFESSOR$223,011 Same NTEE code H92, revenue differs more than 10x, same state
THE PANORAMA INSTITUTE OF MOLECULAR MEDICINECAH92 $65,313$42,054 CHIEF EXECUTIVE OFFICER$0 Same NTEE code H92, revenue differs more than 10x, same state
BIOMEDICAL RESEARCH INSTITUTE OF SOUTHERN CALIFORNIACAH92 $141,627$136,871 PRESIDENT AND CEO$29,482 Same NTEE code H92, revenue differs more than 10x, same state
FOGARTY INSTITUTE FOR INNOVATIONCAH92 $2,887,855$7,841,457 CHIEF STRATEGY OFFICER$377,860 Same NTEE code H92, revenue differs more than 10x, same state
LIFESPAN RESEARCH INSTITUTIONCAH92 $1,799,122$6,520,518 Chief Executive Officer$292,427 Same NTEE code H92, revenue differs more than 10x, same state
SOUTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATIONCAH92 $2,941,163$2,335,904 Chair$419,756 Same NTEE code H92, revenue differs more than 10x, same state
GENETIC INFORMATION RESEARCH INSTITUTECAH92 $617,227$490,110 Trustee$132,779 Same NTEE code H92, revenue differs more than 10x, same state
PINEHURST BIOMEDICAL FOUNDATIONCAH92 $8$60,229 CEO$0 Same NTEE code H92, revenue differs more than 10x, same state
BIOMOLECULAR ULTRASOUND AND SONOGENETICS CONFERENCE ORG INCCAH92 $123,888$102,655 Secretary$0 Same NTEE code H92, revenue differs more than 10x, same state
SERVAREGMPCAH92 $2,328,476$2,353,600 EXECUTIVE DIRECTOR$182,850 Same NTEE code H92, revenue differs more than 10x, same state
AGOURON INSTITUTECAH92 $1,853,788$2,575,826 SCIENTIST$272,898 Same NTEE code H92, revenue differs more than 10x, same state
CALIFORNIA SOCIETY FOR BIOMEDICAL RESEARCHCAH92 $72,075$85,444 Executive Direc$36,360 Same NTEE code H92, revenue differs more than 10x, same state

Who funds organizations like this

Grantors that funded the 100 most similar organizations. Ranked by total given to them. Foundations (990-PF) and donor-advised fund sponsors only. Same matching as Funders above (by EIN, or by name for foundations).

GrantorTotal givenGrantsOrganizations fundedTypeYearsWhich ones
SILICON VALLEY COMMUNITY FOUNDATION $583,247,89053 20DAF sponsor2011–2024 CHAN ZUCKERBERG BIOHUB INC; J DAVID GLADSTONE INSTITUTES; JACKSON LABORATORY; WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH and 16 more
GATES FOUNDATION $505,795,372194 15Private foundation2010–2024 SCRIPPS RESEARCH INSTITUTE; GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC; FOUNDATION FOR THE NATIONAL INSTITUTE OF HEALTH INC; California Institute for BioMedical and 11 more
CHAN ZUCKERBERG INITIATIVE FOUNDATION $382,645,98311 1Private foundation2017–2024 CHAN ZUCKERBERG BIOHUB INC
ENTERTAINMENT INDUSTRY FOUNDATION $300,913,63116 3DAF sponsor2011–2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH; INSTITUTE FOR CANCER RESEARCH; LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL
GARY AND MARY WEST HEALTH ENDOWMENTINC $165,717,4329 1Private foundation2014–2022 GARY AND MARY WEST HEALTH INSTITUTE
DECHOMAI FOUNDATION INC $135,094,7302 1DAF sponsor2022–2024 ARC RESEARCH INSTITUTE
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY $76,659,00012 2DAF sponsor2016–2024 MORGRIDGE INSTITUTE FOUNDATION INC; J DAVID GLADSTONE INSTITUTES
VANGUARD CHARITABLE ENDOWMENT PROGRAM $73,716,48267 23DAF sponsor2020–2024 ARC RESEARCH INSTITUTE; THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY; SCRIPPS RESEARCH INSTITUTE; PARKINSONS FOUNDATION INC and 19 more
GARY AND MARY WEST CHARITABLE TRUST $58,000,0002 1Private foundation2023–2024 GARY AND MARY WEST HEALTH INSTITUTE
FIDELITY INVESTMENTS CHARITABLE GIFT FUND funds this one $56,529,062196 35DAF sponsor2016–2024 SCRIPPS RESEARCH INSTITUTE; PARKINSONS FOUNDATION INC; FOUNDATION FOR THE NATIONAL INSTITUTE OF HEALTH INC; THE MEDICAL UNIVERSITY OF SOUTH CAROLINA FOUNDATION and 31 more
DONOR ADVISED CHARITABLE GIVING funds this one $44,404,380190 28DAF sponsor2014–2024 J DAVID GLADSTONE INSTITUTES; ARC RESEARCH INSTITUTE; SCRIPPS RESEARCH INSTITUTE; THE MEDICAL UNIVERSITY OF SOUTH CAROLINA FOUNDATION and 24 more
LK WHITTIER FOUNDATION $33,000,0003 1Private foundation2020–2022 J DAVID GLADSTONE INSTITUTES
JOHNS HOPKINS UNIVERSITY funds this one $28,320,465116 18DAF sponsor2009–2024 ARKANSAS CHILDRENS HOSPITAL RESEARCH INSTITUTE; ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION; LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL; CHILDRENS RESEARCH INSTITUTE and 14 more
NATIONAL PHILANTHROPIC TR funds this one $26,322,606113 27DAF sponsor2014–2024 ARC RESEARCH INSTITUTE; THE MEDICAL UNIVERSITY OF SOUTH CAROLINA FOUNDATION; STEADMAN PHILIPPON RESEARCH INSTITUTE; GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC and 23 more
TOSA FOUNDATION $25,000,0001 1Private foundation2024–2024 MORGRIDGE INSTITUTE FOUNDATION INC

The full list · all similar organizations

Where the money went

Every expense line on each return, biggest first: Form 990 Part IX (with its program, management and fundraising columns), 990-EZ Part I, or 990-PF Part I. Event marks lines the organization itself describes as events. “Events” in each summary adds those lines, conferences and meetings, and the direct costs of fundraising events. Unusual is not the same as improper. Many of these patterns have ordinary explanations. Check the filing.

2024 · Form 990 · $116,107,616 spent · pay $67,796,159 · grants $0 · events $948,161
LineAs describedTotalProgramManagementFundraisingShare
Other salaries and wages $50,537,718$40,304,124$9,301,975$931,619 43.5%
Other (as described)SCIENTIFIC COLLABORATIO $13,371,531$13,371,531-- 11.5%
Other (as described)RESARCH SUPPLIES & SERV $9,114,792$9,114,792-- 7.9%
Other employee benefits $8,798,791$6,810,223$1,848,631$139,937 7.6%
Occupancy $6,272,585$5,837,695$410,611$24,279 5.4%
Depreciation and depletion $5,621,560$5,235,921$363,715$21,924 4.8%
Office expenses $5,312,286$4,854,687$385,381$72,218 4.6%
Pension plan contributions $3,413,569$2,682,024$707,734$23,811 2.9%
Payroll taxes $3,377,392$2,580,106$727,583$69,703 2.9%
Information technology $1,910,820$1,328,124$542,389$40,307 1.6%
Pay: officers, directors, trustees, key employees $1,668,689$216,557$1,418,689$33,443 1.4%
Interest $962,864$896,812$62,297$3,755 0.8%
Conferences, conventions and meetings $948,161$597,449$334,317$16,395 0.8%
Fees: management $881,938$248,022$460,449$173,467 0.8%
Fees: other services $758,103$595,376$155,614$7,113 0.7%
All other expenses $727,777$201,760$330,504$195,513 0.6%
Fees: investment management $600,112-$600,112- 0.5%
Fees: legal $577,767$40,121$537,646- 0.5%
Other (as described)RECRUITMENT $368,062$279,904$86,483$1,675 0.3%
Travel $290,772$243,322$43,818$3,632 0.3%
Insurance $231,487-$231,487- 0.2%
Fees: accounting $224,028-$224,028- 0.2%
Other (as described)TUITION FEES $135,017$135,017-- 0.1%
Fees: lobbying $1,500-$1,500- 0.0%
Advertising and promotion $295$295-- 0.0%
Total$116,107,616100%

View the filing

2023 · Form 990 · $111,174,592 spent · pay $63,300,127 · grants $0 · events $1,459,011
LineAs describedTotalProgramManagementFundraisingShare
Other salaries and wages $47,639,883$38,317,433$8,456,820$865,630 42.9%
Other (as described)SCIENTIFIC COLLABORATIONS $11,008,033$11,008,033$0$0 9.9%
Other (as described)RESEARCH SUPPLIES & SVCS $9,888,051$9,887,929$3$119 8.9%
Other employee benefits $7,624,582$5,886,415$1,376,517$361,650 6.9%
Occupancy $6,575,946$6,149,262$401,887$24,797 5.9%
Office expenses $5,634,672$5,076,466$540,521$17,685 5.1%
Depreciation and depletion $5,369,141$5,023,905$324,833$20,403 4.8%
Payroll taxes $3,132,386$2,412,870$653,549$65,967 2.8%
Pension plan contributions $3,096,876$2,417,032$625,235$54,609 2.8%
Information technology $1,689,633$1,215,046$441,169$33,418 1.5%
Pay: officers, directors, trustees, key employees $1,465,150$32,500$1,286,400$146,250 1.3%
Interest $1,151,762$1,077,703$69,682$4,377 1.0%
Conferences, conventions and meetings $1,004,212$662,268$338,044$3,900 0.9%
Fees: legal $928,176$62,346$855,330$10,500 0.8%
All other expenses $922,897$63,824$804,638$54,435 0.8%
Fees: other services $861,908$569,281$243,903$48,724 0.8%
Fees: management $809,508$273,878$453,260$82,370 0.7%
Fees: investment management $679,787$0$679,787$0 0.6%
Fees: accounting $421,627$0$421,627$0 0.4%
Travel $361,891$328,382$30,749$2,760 0.3%
Pay: disqualified persons $341,250$0$341,250$0 0.3%
Insurance $230,910$0$230,910$0 0.2%
Other (as described)RECRUITMENT $220,928$151,902$62,615$6,411 0.2%
Other (as described)TUITION FEES $112,908$112,908$0$0 0.1%
Fees: lobbying $1,500$0$1,500$0 0.0%
Advertising and promotion $975$0$975$0 0.0%
Fundraising events Eventdirect expenses; gross income $422,000$454,799reported apart
Total$111,174,592100%

View the filing

2022 · Form 990 · $103,397,718 spent · pay $58,193,349 · grants $0 · events $1,277,926
LineAs describedTotalProgramManagementFundraisingShare
Other salaries and wages $44,095,826$34,324,157$8,614,372$1,157,297 42.6%
Other (as described)SCIENTIFIC COLLABORATIONS $10,383,161$10,383,161$0$0 10.0%
Other (as described)RESEARCH SUPPLIES & SVCS $9,633,741$9,631,881$1,860- 9.3%
Other employee benefits $7,401,327$5,628,997$1,597,200$175,130 7.2%
Occupancy $6,742,030$6,300,154$415,040$26,836 6.5%
Office expenses $5,365,932$4,919,280$385,735$60,917 5.2%
Depreciation and depletion $5,180,844$4,846,162$313,959$20,723 5.0%
Payroll taxes $2,833,481$2,134,035$634,473$64,973 2.7%
Pension plan contributions $2,808,206$2,186,957$574,808$46,441 2.7%
Information technology $1,494,399$1,053,828$407,175$33,396 1.4%
Interest $1,319,092$1,233,879$79,937$5,276 1.3%
Conferences, conventions and meetings $1,277,926$665,430$605,750$6,746 1.2%
Pay: officers, directors, trustees, key employees $1,054,509$0$937,603$116,906 1.0%
Fees: other services $904,348$721,866$149,758$32,724 0.9%
Fees: investment management $553,900$0$553,900$0 0.5%
Fees: management $531,870$174,399$300,165$57,306 0.5%
Fees: accounting $440,906$0$440,906$0 0.4%
All other expenses $389,957$147,093$199,843$43,021 0.4%
Travel $275,140$243,583$28,472$3,085 0.3%
Other (as described)RECRUITMENT $262,717$174,340$49,521$38,856 0.3%
Insurance $220,382$0$220,382$0 0.2%
Other (as described)TUITION FEES $126,457$126,457$0$0 0.1%
Fees: legal $100,052$58,449$41,603$0 0.1%
Fees: lobbying $1,500$0$1,500$0 0.0%
Advertising and promotion $15$0$15$0 0.0%
Total$103,397,718100%

View the filing

2021 · Form 990 · $106,781,079 spent · pay $59,973,447 · grants $0 · events $552,326
LineAs describedTotalProgramManagementFundraisingShare
Other salaries and wages $40,485,652$31,224,439$8,513,846$747,367 37.9%
Other employee benefits $11,937,448$5,227,156$6,619,219$91,073 11.2%
Other (as described)RESEARCH SUPPLIES & SVCS $9,820,069$9,820,069$0$0 9.2%
Other (as described)SCIENTIFIC COLLABORATIONS $8,751,368$8,751,368$0$0 8.2%
Occupancy $7,902,738$7,415,941$481,228$5,569 7.4%
Depreciation and depletion $6,870,296$6,451,208$414,279$4,809 6.4%
Office expenses $5,193,586$4,771,381$386,349$35,856 4.9%
Payroll taxes $2,780,289$1,999,330$727,325$53,634 2.6%
Pension plan contributions $2,689,720$2,115,179$564,075$10,466 2.5%
Pay: officers, directors, trustees, key employees $2,080,338$134,516$1,945,822$0 1.9%
Interest $1,451,168$1,362,647$87,505$1,016 1.4%
Information technology $1,392,845$937,330$409,163$46,352 1.3%
Fees: management $1,392,039$209,911$1,091,797$90,331 1.3%
Fees: other services $763,880$581,804$129,388$52,688 0.7%
Fees: investment management $663,576$0$663,576$0 0.6%
Conferences, conventions and meetings $552,326$327,575$200,566$24,185 0.5%
Other (as described)RECRUITMENT $525,227$201,824$307,176$16,227 0.5%
Fees: accounting $412,305$0$412,305$0 0.4%
Fees: legal $389,089$72,100$316,989$0 0.4%
Insurance $221,813$0$221,813$0 0.2%
Travel $192,838$152,811$39,851$176 0.2%
Other (as described)TUITION FEES $155,790$155,790$0$0 0.1%
All other expenses $154,659$63,027$37,985$53,647 0.1%
Advertising and promotion $2,020$2,000$20$0 0.0%
Total$106,781,079100%

View the filing

2020 · Form 990 · $108,924,075 spent · pay $58,840,604 · grants $0 · events $178,194
LineAs describedTotalProgramManagementFundraisingShare
Other salaries and wages $43,157,602$33,177,744$9,166,487$813,371 39.6%
Other (as described)RESEARCH SUPPLIES & SVCS $10,801,063$10,801,063-- 9.9%
Occupancy $9,447,676$8,388,325$984,079$75,272 8.7%
Other (as described)SCIENTIFIC COLLABORATIONS $8,986,112$8,986,112-- 8.2%
Other employee benefits $7,433,905$5,316,296$2,017,852$99,757 6.8%
Depreciation and depletion $6,564,887$5,832,246$680,122$52,519 6.0%
Office expenses $5,357,657$4,928,905$406,900$21,852 4.9%
Pension plan contributions $3,021,491$2,328,480$650,673$42,338 2.8%
Payroll taxes $2,823,117$2,103,853$669,660$49,604 2.6%
Pay: officers, directors, trustees, key employees $2,404,489$5,793$2,398,696- 2.2%
Fees: management $1,910,166$366,818$1,476,011$67,337 1.8%
Interest $1,616,248$1,435,875$167,443$12,930 1.5%
Fees: other services $1,334,440$1,120,804$187,550$26,086 1.2%
Information technology $1,282,857$900,588$351,493$30,776 1.2%
Other (as described)RECRUITMENT $805,509$274,008$421,147$110,354 0.7%
Fees: investment management $654,971-$654,971- 0.6%
Fees: accounting $372,221-$372,221- 0.3%
Fees: legal $276,367$49,245$227,122- 0.3%
Insurance $199,066-$199,066- 0.2%
Conferences, conventions and meetings $178,194$133,266$36,560$8,368 0.2%
Other (as described)TUITION FEES $130,180$130,180-- 0.1%
All other expenses $129,222$31,063$61,472$36,687 0.1%
Travel $28,152$25,981$2,164$7 0.0%
Advertising and promotion $8,483$500$7,983- 0.0%
Total$108,924,075100%

View the filing

2019 · Form 990 · $112,647,929 spent · pay $62,755,446 · grants $0 · events $1,088,270
LineAs describedTotalProgramManagementFundraisingShare
Other salaries and wages $47,298,550$37,613,090$8,872,115$813,345 42.0%
Occupancy $10,985,009$10,013,170$903,696$68,143 9.8%
Other (as described)RESEARCH SUPPLIES & SVCS $9,195,443$9,195,443$0$0 8.2%
Other (as described)Scientific collaborations $8,532,168$8,532,168$0$0 7.6%
Other employee benefits $7,516,566$5,939,878$1,480,539$96,149 6.7%
Depreciation and depletion $7,050,756$6,430,289$576,752$43,715 6.3%
Office expenses $5,649,705$4,967,362$631,083$51,260 5.0%
Pension plan contributions $3,233,587$2,496,251$681,134$56,202 2.9%
Payroll taxes $2,974,657$2,241,787$680,054$52,816 2.6%
Interest $1,778,605$1,622,088$145,490$11,027 1.6%
Pay: officers, directors, trustees, key employees $1,732,086$154,502$1,577,584$0 1.5%
Information technology $1,250,113$920,349$299,493$30,271 1.1%
Fees: management $1,193,907$152,805$947,216$93,886 1.1%
Conferences, conventions and meetings $928,370$672,391$247,820$8,159 0.8%
Fees: other services $904,054$634,330$264,443$5,281 0.8%
Fees: investment management $628,171$0$628,171$0 0.6%
Fees: legal $481,077$38,648$442,429$0 0.4%
Fees: accounting $348,063$0$348,063$0 0.3%
Travel $298,833$261,466$35,489$1,878 0.3%
All other expenses $294,657$96,234$92,750$105,673 0.3%
Insurance $184,870$0$184,870$0 0.2%
Other (as described)TUITION FEES $116,358$116,358$0$0 0.1%
Other (as described)BAD DEBT $58,322$0$58,322$0 0.1%
Advertising and promotion $12,502$0$12,502$0 0.0%
Fees: lobbying $1,500$0$1,500$0 0.0%
Fundraising events Eventdirect expenses; gross income $27,000$159,900reported apart
Total$112,647,929100%

View the filing

2018 · Form 990 · $186,280,858 spent · pay $65,811,734 · grants $0 · events $1,400,810
LineAs describedTotalProgramManagementFundraisingShare
Other (as described)CONTRIBUTED ASSETS $65,411,144$0$65,411,144$0 35.1%
Other salaries and wages $49,409,343$39,978,741$8,753,432$677,170 26.5%
Occupancy $12,201,330$10,856,400$1,273,424$71,506 6.5%
Other (as described)RESEARCH SUPPLIES & SVCS $10,410,668$10,410,668$0$0 5.6%
Depreciation and depletion $8,968,041$8,121,441$794,225$52,375 4.8%
Other (as described)SCIENTIFIC COLLABORATIONS $8,089,399$8,089,399$0$0 4.3%
Other employee benefits $8,054,800$6,589,802$1,401,993$63,005 4.3%
Office expenses $6,366,860$5,663,217$654,581$49,062 3.4%
Pension plan contributions $3,325,036$2,636,505$632,128$56,403 1.8%
Payroll taxes $3,001,930$2,303,943$655,231$42,756 1.6%
Interest $1,919,481$1,747,687$158,933$12,861 1.0%
Information technology $1,459,944$1,107,654$314,321$37,969 0.8%
Pay: officers, directors, trustees, key employees $1,240,167$154,502$1,085,665$0 0.7%
Fees: management $1,084,184$417,876$610,208$56,100 0.6%
Conferences, conventions and meetings $1,046,410$805,009$202,674$38,727 0.6%
Fees: other services $818,904$634,526$172,704$11,674 0.4%
Pay: disqualified persons $780,458$0$780,458$0 0.4%
Fees: investment management $697,100$0$697,100$0 0.4%
Fees: legal $643,181$54,570$588,611$0 0.3%
Travel $425,568$366,755$51,894$6,919 0.2%
Fees: accounting $375,420$0$375,420$0 0.2%
All other expenses $304,031$186,619$40,373$77,039 0.2%
Other (as described)Bad Debt $222,285$0$222,285$0 0.1%
Advertising and promotion $23,974$0$108$23,866 0.0%
Fees: lobbying $1,200$0$1,200$0 0.0%
Fundraising events Eventdirect expenses; gross income $59,487$354,400reported apart
Total$186,280,858100%

View the filing

2017 · Form 990 · $143,519,364 spent · pay $76,269,756 · grants $0 · events $1,481,742
LineAs describedTotalProgramManagementFundraisingShare
Other salaries and wages $57,562,490$46,896,620$9,887,060$778,810 40.1%
Depreciation and depletion $13,919,772$12,560,655$1,294,091$65,026 9.7%
Occupancy $13,737,146$12,162,746$1,488,145$86,255 9.6%
Other (as described)RESEARCH SUPPLIES & SERVICES $13,215,854$13,215,854$0$0 9.2%
Other employee benefits $8,779,133$7,344,977$1,359,065$75,091 6.1%
Office expenses $7,794,564$6,985,035$762,007$47,522 5.4%
Other (as described)SCIENTIFIC COLLABORATIONS $7,157,418$7,157,418$0$0 5.0%
Pension plan contributions $3,771,796$3,082,013$638,088$51,695 2.6%
Payroll taxes $3,459,406$2,712,977$693,443$52,986 2.4%
Pay: officers, directors, trustees, key employees $2,696,931$158,377$2,538,554- 1.9%
Interest $2,044,147$1,853,837$173,344$16,966 1.4%
Fees: management $1,721,171$867,152$845,514$8,505 1.2%
Information technology $1,437,250$1,066,233$340,494$30,523 1.0%
Fees: other services $1,274,282$561,743$701,480$11,059 0.9%
Conferences, conventions and meetings $1,202,241$949,079$224,784$28,378 0.8%
Fees: legal $1,147,792$38,754$1,109,038$0 0.8%
Travel $720,200$639,575$72,121$8,504 0.5%
Other (as described)BAD DEBT $576,628$0$576,628$0 0.4%
All other expenses $437,485$242,542$106,103$88,840 0.3%
Other (as described)CONTRIBUTED ASSETS $387,651$0$387,651$0 0.3%
Fees: accounting $384,853$0$384,853$0 0.3%
Advertising and promotion $51,701$2,625$0$49,076 0.0%
Insurance $22,857$0$22,857$0 0.0%
Fees: investment management $15,536$0$15,536$0 0.0%
Fees: lobbying $1,060$0$1,060$0 0.0%
Fundraising events Eventdirect expenses; gross income $52,500$279,501reported apart
Total$143,519,364100%

View the filing

2016 · Form 990 · $146,845,314 spent · pay $79,341,143 · grants $0 · events $1,473,334
LineAs describedTotalProgramManagementFundraisingShare
Other salaries and wages $60,650,213$48,931,572$10,917,314$801,327 41.3%
Other (as described)RESEARCH SUPPLIES & SERV. $14,706,631$14,706,631$0$0 10.0%
Occupancy $13,450,575$12,058,762$1,307,241$84,572 9.2%
Depreciation and depletion $13,127,059$11,843,510$1,225,692$57,857 8.9%
Office expenses $8,813,036$7,869,629$845,653$97,754 6.0%
Other employee benefits $8,692,549$7,145,436$1,442,886$104,227 5.9%
Other (as described)Scientific collaborations $4,567,950$4,567,950$0$0 3.1%
Pension plan contributions $3,977,082$3,252,754$675,228$49,100 2.7%
Payroll taxes $3,629,916$2,821,696$751,430$56,790 2.5%
Pay: officers, directors, trustees, key employees $2,391,383$243,210$2,148,173$0 1.6%
Interest $2,162,878$1,961,514$183,412$17,952 1.5%
Other (as described)Bad Debt $1,891,263$0$1,891,263$0 1.3%
Fees: management $1,755,607$940,071$743,178$72,358 1.2%
Fees: other services $1,508,777$710,539$783,576$14,662 1.0%
Information technology $1,401,290$1,102,617$263,472$35,201 1.0%
Conferences, conventions and meetings $1,193,091$877,587$284,224$31,280 0.8%
Fees: legal $1,069,842$52,701$1,017,141$0 0.7%
Travel $554,902$457,532$93,631$3,739 0.4%
Fees: accounting $400,371$0$400,371$0 0.3%
All other expenses $364,979$113,153$150,221$101,605 0.2%
Other (as described)Recruitment $250,018$189,837$60,065$116 0.2%
Insurance $146,793-$146,793$0 0.1%
Fees: lobbying $67,275$0$67,275$0 0.0%
Advertising and promotion $56,734$3,155$7,777$45,802 0.0%
Fees: investment management $15,100$0$15,100$0 0.0%
Fundraising events Eventdirect expenses; gross income $57,000$280,243reported apart
Total$146,845,314100%

View the filing

2015 · Form 990 · $142,368,594 spent · pay $77,528,317 · grants $0 · events $1,415,311
LineAs describedTotalProgramManagementFundraisingShare
Other salaries and wages $58,397,347$47,973,116$9,374,837$1,049,394 41.0%
Occupancy $13,666,798$12,214,014$1,342,832$109,952 9.6%
Other (as described)RESEARCH SUPPLIES & SERV. $12,961,698$12,961,698-- 9.1%
Depreciation and depletion $12,710,838$11,389,200$1,232,173$89,465 8.9%
Office expenses $8,212,293$7,475,191$650,838$86,264 5.8%
Other employee benefits $8,135,849$6,812,027$1,204,963$118,859 5.7%
Interest $5,177,017$4,366,294$770,762$39,961 3.6%
Pension plan contributions $3,873,972$3,217,835$606,141$49,996 2.7%
Other (as described)SCIENTIFIC COLLABORATIONS $3,863,964$3,863,964$0$0 2.7%
Pay: officers, directors, trustees, key employees $3,584,703$237,062$3,347,641$0 2.5%
Payroll taxes $3,536,446$2,748,283$715,861$72,302 2.5%
Fees: management $1,534,442$844,795$683,773$5,874 1.1%
Information technology $1,297,036$960,885$303,392$32,759 0.9%
Conferences, conventions and meetings $1,225,902$943,532$260,859$21,511 0.9%
Fees: legal $1,086,661$47,704$1,038,815$142 0.8%
Fees: other services $952,032$518,959$420,724$12,349 0.7%
Travel $565,634$469,924$87,540$8,170 0.4%
Other (as described)RECRUITMENT $544,344$250,798$279,054$14,492 0.4%
Fees: accounting $366,170$0$366,170$0 0.3%
All other expenses $222,796$99,020$24,086$99,690 0.2%
Fees: lobbying $195,400$0$195,400$0 0.1%
Insurance $101,636$0$101,636$0 0.1%
Other (as described)BAD DEBT $95,594-$95,594- 0.1%
Advertising and promotion $40,776$10,985$9,559$20,232 0.0%
Fees: investment management $19,246$0$19,246$0 0.0%
Fundraising events Eventdirect expenses; gross income $45,150$189,409reported apart
Total$142,368,594100%

View the filing

2014 · Form 990 · $151,893,967 spent · pay $77,062,612 · grants $0 · events $1,512,166
LineAs describedTotalProgramManagementFundraisingShare
Other salaries and wages $56,763,016$48,603,328$7,604,718$554,970 37.4%
Depreciation and depletion $14,811,018$13,405,174$1,311,093$94,751 9.8%
Occupancy $14,038,551$12,543,861$1,382,227$112,463 9.2%
Other (as described)RESEARCH SUPPLIES & SERV. $13,598,215$13,598,215$0$0 9.0%
Other employee benefits $9,467,783$7,946,423$1,401,109$120,251 6.2%
Office expenses $8,057,300$7,266,024$641,667$149,609 5.3%
Other (as described)SCIENTIFIC COLLABORATIONS $7,178,024$7,178,024$0$0 4.7%
All other expenses $4,481,894$90,057$4,187,125$204,712 3.0%
Pension plan contributions $4,119,003$3,260,631$808,358$50,014 2.7%
Payroll taxes $3,541,239$2,871,698$621,541$48,000 2.3%
Interest $3,329,574$3,025,919$276,020$27,635 2.2%
Pay: officers, directors, trustees, key employees $3,011,421$242,400$2,769,021$0 2.0%
Fees: management $2,872,813$1,010,906$1,719,531$142,376 1.9%
Information technology $1,347,846$1,073,777$248,905$25,164 0.9%
Conferences, conventions and meetings $1,273,430$920,057$325,128$28,245 0.8%
Fees: other services $1,038,092$702,987$323,512$11,593 0.7%
Travel $678,776$531,555$135,554$11,667 0.4%
Fees: legal $578,459$52,191$526,268$0 0.4%
Other (as described)RECRUITMENT $522,629$256,755$249,619$16,255 0.3%
Fees: accounting $352,559$0$352,559$0 0.2%
Fees: professional fundraisers $261,304--$261,304 0.2%
Fees: lobbying $169,315$0$169,315$0 0.1%
Pay: disqualified persons $160,150$0$16,015$144,135 0.1%
Insurance $86,495$0$86,495$0 0.1%
Other (as described)UBI TAXES $73,866$0$73,866$0 0.0%
Advertising and promotion $61,739$0$16,701$45,038 0.0%
Fees: investment management $19,456$0$19,456$0 0.0%
Fundraising events Eventdirect expenses; gross income $33,000$238,736reported apart
Total$151,893,967100%

View the filing

2013 · Form 990 · $142,659,251 spent · pay $74,256,935 · grants $0 · events $1,569,607
LineAs describedTotalProgramManagementFundraisingShare
Other salaries and wages $56,135,155$47,836,192$7,269,248$1,029,715 39.3%
Depreciation and depletion $17,374,712$15,445,839$1,809,715$119,158 12.2%
Occupancy $13,688,682$12,218,346$1,361,494$108,842 9.6%
Other (as described)Research supplies & serv $10,690,315$10,690,315$0$0 7.5%
Office expenses $9,173,659$8,489,036$594,648$89,975 6.4%
Other employee benefits $8,426,086$7,240,288$1,032,736$153,062 5.9%
Other (as described)Scientific collaborations $5,180,540$5,180,540$0$0 3.6%
Pension plan contributions $3,780,907$3,159,424$552,064$69,419 2.7%
Interest $3,439,937$3,126,514$285,162$28,261 2.4%
Payroll taxes $3,433,164$2,799,450$556,390$77,324 2.4%
Pay: officers, directors, trustees, key employees $2,287,173$537,746$1,749,427$0 1.6%
Fees: management $2,203,331$839,961$1,354,785$8,585 1.5%
Information technology $1,359,158$1,068,848$260,042$30,268 1.0%
Conferences, conventions and meetings $1,312,067$975,572$311,403$25,092 0.9%
Fees: other services $989,957$736,041$245,711$8,205 0.7%
Travel $679,657$576,023$87,670$15,964 0.5%
Fees: legal $584,109$52,576$523,346$8,187 0.4%
Other (as described)Miscellaneous $490,678$153,296$203,880$133,502 0.3%
Other (as described)Recruitment $448,679$157,550$290,666$463 0.3%
Fees: accounting $399,991$0$399,991$0 0.3%
Pay: disqualified persons $194,450$0$19,445$175,005 0.1%
Fees: lobbying $141,533$0$141,533$0 0.1%
Insurance $82,695$0$82,695$0 0.1%
Fees: professional fundraisers $80,888--$80,888 0.1%
Advertising and promotion $65,538$10,843$3,509$51,186 0.0%
Fees: investment management $16,190$0$16,190$0 0.0%
Fundraising events Eventdirect expenses; gross income $43,800$257,540reported apart
Total$142,659,251100%

View the filing

2012 · Form 990 · $148,976,090 spent · pay $79,343,211 · grants $0 · events $1,558,764
LineAs describedTotalProgramManagementFundraisingShare
Other salaries and wages $60,510,538$50,837,956$8,237,101$1,435,481 40.6%
Depreciation and depletion $19,065,947$16,654,008$2,263,256$148,683 12.8%
Occupancy $13,284,137$11,802,321$1,364,933$116,883 8.9%
Other (as described)RESEARCH SUPPLIES & EXPENSES $10,479,721$10,479,721-- 7.0%
Office expenses $9,308,668$8,628,160$589,168$91,340 6.2%
Other employee benefits $8,906,179$7,220,690$1,521,434$164,055 6.0%
Other (as described)SCIENTIFIC COLLABORATIONS $6,616,691$6,616,691-- 4.4%
Pension plan contributions $4,167,689$3,388,695$689,405$89,589 2.8%
Payroll taxes $3,725,968$3,053,466$583,449$89,053 2.5%
Interest $3,710,284$3,367,833$307,574$34,877 2.5%
Pay: officers, directors, trustees, key employees $1,841,699$2,115,745-$274,046- 1.2%
Fees: management $1,464,931$1,119,204$345,480$247 1.0%
Information technology $1,315,093$1,009,512$281,248$24,333 0.9%
Conferences, conventions and meetings $1,194,284$844,290$319,367$30,627 0.8%
Travel $785,657$678,326$85,927$21,404 0.5%
Fees: other services $756,085$575,134$164,463$16,488 0.5%
Other (as described)RECRUITMENT $385,513$330,049$30,955$24,509 0.3%
Fees: legal $379,952$44,781$335,171- 0.3%
Fees: accounting $305,901-$305,901- 0.2%
Other (as described)MISCELLANEOUS $272,826$119,528$48,879$104,419 0.2%
Pay: disqualified persons $191,138$191,138-- 0.1%
Fees: lobbying $123,133$245$122,888- 0.1%
Insurance $85,144-$85,144- 0.1%
Advertising and promotion $53,399$220$15,239$37,940 0.0%
Fees: professional fundraisers $33,225--$33,225 0.0%
Fees: investment management $12,288-$12,288- 0.0%
Fundraising events Eventdirect expenses; gross income -$364,480reported apart
Total$148,976,090100%

View the filing

2011 · Form 990 · $158,377,766 spent · pay $82,248,203 · grants $0 · events $1,994,760
LineAs describedTotalProgramManagementFundraisingShare
Other salaries and wages $61,993,413$51,424,649$8,872,346$1,696,418 39.1%
Depreciation and depletion $19,986,867$17,405,538$2,396,889$184,440 12.6%
Occupancy $13,817,632$12,302,843$1,383,193$131,596 8.7%
Other (as described)Research supplies & services $12,684,932$12,684,932-- 8.0%
Office expenses $9,820,758$9,107,239$589,275$124,244 6.2%
Other employee benefits $8,713,053$7,263,485$1,252,448$197,120 5.5%
Other (as described)Scientific collaborations $6,324,867$6,324,867-- 4.0%
Interest $4,030,913$3,659,666$333,356$37,891 2.5%
Pension plan contributions $3,909,187$3,121,685$691,364$96,138 2.5%
Pay: officers, directors, trustees, key employees $3,820,675$2,332,592$1,488,083- 2.4%
Payroll taxes $3,811,875$3,081,173$621,288$109,414 2.4%
Information technology $1,741,934$1,238,920$495,559$7,455 1.1%
Fees: legal $1,566,460$61,955$1,504,505- 1.0%
Conferences, conventions and meetings $1,477,921$1,058,675$362,528$56,718 0.9%
Fees: management $1,298,851$1,093,605$205,211$35 0.8%
Travel $874,746$735,935$110,666$28,145 0.6%
Fees: other services $808,701$453,669$222,301$132,731 0.5%
Fees: accounting $498,836-$498,836- 0.3%
Other (as described)Miscellaneous $426,334$126,007$114,129$186,198 0.3%
Other (as described)Recruitment $349,094$181,481$53,369$114,244 0.2%
Fees: professional fundraisers $196,445--$196,445 0.1%
Fees: lobbying $126,038-$126,038- 0.1%
Insurance $53,377-$53,377- 0.0%
Advertising and promotion $44,857-$6,656$38,201 0.0%
Fundraising events Eventdirect expenses; gross income -$516,839reported apart
Total$158,377,766100%

View the filing

2010 · Form 990 · $161,165,052 spent · pay $82,307,396 · grants $0 · events $2,011,922
LineAs describedTotalProgramManagementFundraisingShare
Other salaries and wages $62,616,458$51,626,280$9,228,335$1,761,843 38.9%
Depreciation and depletion $19,735,677$17,140,216$2,406,262$189,199 12.2%
Occupancy $13,565,937$12,063,385$1,375,834$126,718 8.4%
Other (as described)RESEARCH SUPPLIES & SERVICES $12,682,026$12,682,026-- 7.9%
Office expenses $9,427,632$8,605,761$634,503$187,368 5.8%
Other employee benefits $8,786,127$7,063,490$1,516,249$206,388 5.5%
Other (as described)SCIENTIFIC COLLABORATIONS $6,426,098$6,426,098-- 4.0%
Interest $4,317,034$3,912,960$363,494$40,580 2.7%
Payroll taxes $3,865,752$3,105,928$649,624$110,200 2.4%
Pension plan contributions $3,537,594$2,742,477$684,684$110,433 2.2%
Pay: officers, directors, trustees, key employees $3,501,465$1,625,080$1,876,385- 2.2%
Fees: legal $2,542,522$136,000$2,406,522- 1.6%
Information technology $1,998,758$1,458,225$466,857$73,676 1.2%
Fees: other services $1,787,582$1,185,217$448,643$153,722 1.1%
Conferences, conventions and meetings $1,597,112$1,029,398$464,628$103,086 1.0%
Fees: management $1,523,488$1,115,182$315,513$92,793 0.9%
Travel $863,319$689,441$138,321$35,557 0.5%
Other (as described)RECRUITMENT $823,817$723,955$73,370$26,492 0.5%
Other (as described)MISCELLANEOUS $743,108$162,353$406,624$174,131 0.5%
Fees: accounting $389,980-$389,980- 0.2%
Fees: lobbying $242,981-$242,981- 0.2%
Advertising and promotion $119,958$296$36,285$83,377 0.1%
Insurance $70,627-$70,627- 0.0%
Fundraising events Eventdirect expenses; gross income -$414,810reported apart
Total$161,165,052100%

View the filing

Federal grants and contracts

Awards from USAspending.gov to a recipient with this organization's name and zip code. Obligations by federal fiscal year (October to September); each award links to its page on usaspending.gov.

Fiscal yearGrants and other assistanceContractsAwards
2027$0$01
2026$48,962,706$084
2025$44,448,623$081
2024$55,764,052$0104
2023$56,152,013$097
2022$69,783,904$0115
2021$57,948,230$0121
2020$64,548,414-$4,842121
2019$58,009,298$100,000127
2018$57,224,036$5,249116
2017$67,759,193$84,842154
2016$56,229,930$0114
2015$50,916,738$5,242113
2014$63,218,001$0123
2013$56,109,949$9,201128
2012$75,749,103$0131
2011$77,065,944$3,627130
2010$84,413,434$0140
2009$82,061,644$0125
2008$59,603,118$35,00073
2007$46,931,303$088
Largest awards · 200 shown
YearAgencyKindProgramDescriptionObligated
2026National Institutes of HealthGrant or other assistanceCANCER CENTERS SUPPORT GRANTS 93.397CANCER CENTER SUPPORT GRANT$4,081,820
2026National Institutes of HealthGrant or other assistanceDRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279NEUROTENSIN 1 ALLOSTERIC MODULATOR FOR THE TREATMENT OF PAIN - PROJECT SUMMARY THE NIH HEAL INITIATIVE AIMS TO TACKLE TWO ONGOING HEALTH CARE CRISES: OPIOID USE$3,855,681
2026National Institutes of HealthGrant or other assistanceBIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859MOLECULAR BASIS OF NUCLEAR PORE FORMATION - PROJECT SUMMARY NUCLEAR PORE COMPLEXES (NPCS) ARE ESSENTIAL PROTEIN ASSEMBLIES THAT CONTROL SELECTIVE TRANSPORT BETW$2,903,176
2026National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866DISCOVERY AND OPTIMIZATION OF APOE4 CORRECTORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE - PROJECT SUMMARY ALZHEIMER'S DISEASE (AD) IS A MAJOR PUBLIC HEALTH CRIS$2,676,401
2026National Institutes of HealthGrant or other assistanceCANCER BIOLOGY RESEARCH 93.396ROLE OF HYPERNUTRITION AND METABOLIC STRESS IN NON-ALCOHOLIC STEATOHEPATITIS (NASH) DRIVEN HEPATOCELLULAR CARCINOMA (HCC) - PROJECT SUMMARY – OVERALL HEPATOCELL$2,272,153
2026National Institutes of HealthGrant or other assistanceCANCER BIOLOGY RESEARCH 93.396REWIRING T CELL EXHAUSTION WITH IMMUNE CHECKPOINT BLOCKADE THERAPY - PROJECT SUMMARY THE GOAL OF THIS PROJECT IS TO DETERMINE WHETHER IT IS POSSIBLE TO PROMOTE $2,024,989
2026National Institutes of HealthGrant or other assistanceBIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859CATALYTIC MECHANISMS, REGULATION, AND ANTI-FIBROTIC ROLES OF THE TMEM2 CELL SURFACE HYALURONIDASE - PROJECT SUMMARY HYALURONAN (HA), A MEMBER OF THE GLYCOSAMINO$1,677,007
2026National Institutes of HealthGrant or other assistanceCARDIOVASCULAR DISEASES RESEARCH 93.837SINGLE-CONSTRUCT GENE THERAPY FOR ENHANCED HEART REPAIR - PROJECT SUMMARY CARDIOVASCULAR DISEASES ARE THE LEADING CAUSE OF DEATH GLOBALLY, RESPONSIBLE FOR NEARL$1,603,648
2026National Institutes of HealthGrant or other assistanceCANCER BIOLOGY RESEARCH 93.396REGULATION OF PDAC METABOLISM AND IMMUNITY BY COLLAGEN AND ITS CLEAVAGE PRODUCTS - ABSTRACT PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) IS A HIGHLY DESMOPLASTIC AND$1,021,269
2026National Institutes of HealthGrant or other assistanceDIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847POST-TRANSCRIPTIONAL REGULATION BY RNA BINDING PROTEINS IN LIVER FIBROSIS - PROJECT SUMMARY CHRONIC LIVER INJURY CAN LEAD TO FIBROSIS, A CONDITION WHERE SCAR TI$910,940
2026National Institutes of HealthGrant or other assistanceDIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847THE NRF2-FBP1 CROSSREGULATORY LOOP AND THE CONTROL OF HEALTHY AND DISEASED LIVER METABOLISM - PROJECT SUMMARY/ABSTRACT FRUCTOSE BISPHOSPHATE PHOSPHATASE (FBP1) $889,840
2026National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866MOLECULAR PATHOBIOLOGY OF SOLUBLE TREM2 IN ALZHEIMER'S DISEASE - PROJECT SUMMARY ALZHEIMER’S DISEASE (AD) IS THE MOST PROMINENT NEURODEGENERATIVE DISORDER WORL$880,491
2026National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866NOVEL NEUROPROTECTIVE ROLES FOR THE ALZHEIMER'S DISEASE RISK GENE SORLA IN TAU PATHOLOGY AND PATHOGENESIS - NUMEROUS MUTATIONAL VARIANTS IN THE SORLA (SORL1) GE$877,445
2026National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866ELUCIDATING A MICROGLIAASSOCIATED ROLE FOR SORLA IN MODULATING AD PATHOGENESIS - PROJECT SUMMARY MUTATIONS IN SORLA (ENCODED BY SORL1) IDENTIFIED THROUGH GWAS $865,606
2026National Institutes of HealthGrant or other assistanceALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855NF-KAPPAB AND MITOCHONDRIAL SIGNALS AS POSITIVE AND NEGATIVE REGULATORS OF INFLAMMATION$815,131
2026National Institutes of HealthGrant or other assistanceCANCER BIOLOGY RESEARCH 93.396COLLAGEN FIBERS AND FRAGMENTS REGULATE PANCREATIC CANCER METABOLISM AND GROWTH. - PROJECT SUMMARY PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) IS CHARACTERIZED BY EX$809,870
2026National Institutes of HealthGrant or other assistanceDIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847NEW CONGENITAL DISORDERS OF GLYCOSYLATION: THERAPY AND MODELS$809,568
2026National Institutes of HealthGrant or other assistanceCANCER TREATMENT RESEARCH 93.395DISCOVERY OF POTENT SELECTIVE INHIBITORS OF THE HISTONE METHYLTRANSFERASE SUV39H1 FOR THE TREATMENT OF CANCER - PROJECT SUMMARY CANCER TREATMENT HAS BEEN TRANSF$809,234
2026National Institutes of HealthGrant or other assistanceCANCER BIOLOGY RESEARCH 93.396CHARACTERIZING THE FUNCTIONS OF NUP210 IN LEUKEMIA - PROJECT SUMMARY NUCLEAR PORE COMPLEXES (NPCS) ARE LARGE MULTIPROTEIN CHANNELS THAT CONNECT THE NUCLEUS WITH$803,681
2026National Institutes of HealthGrant or other assistanceCANCER TREATMENT RESEARCH 93.395SCREENING FOR INHIBITORS OF THE CHROMATIN READER SGF29 - PROJECT SUMMARY AML IS A DEVASTATING DISEASE WITH SURVIVAL RATES OF ONLY 30-35 PERCENT AND CURE-RATES H$772,588
2026National Institutes of HealthGrant or other assistanceALCOHOL RESEARCH PROGRAMS 93.273OPTIMIZATION OF DRUG-LIKE PROPERTIES OF CRFBP-CRF2 NEGATIVE ALLOSTERIC MODULATORS FOR ALCOHOL USE DISORDER - PROJECT SUMMARY THIS APPLICATION, “OPTIMIZATION OF $771,544
2026National Institutes of HealthGrant or other assistanceDIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847IMPROVING PROINSULIN FOLDING TO AMELIORATE TYPE II DIABETES - PROJECT SUMMARY DIABETES IS AMONG THE FASTEST GROWING HEALTH CHALLENGES OF THE 21ST CENTURY, AFFEC$760,498
2026National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866AGING AS A RISK FACTOR AND TARGET FOR PREVENTION OF LIVER CANCER - PROJECT SUMMARY – OVERALL THE INCIDENCES OF LIVER CANCER (PRIMARILY HEPATOCELLULAR CARCINOMA $758,616
2026National Institutes of HealthGrant or other assistanceALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855COMPARATIVE RESISTOMICS OF GRAM-NEGATIVE BACTERIAL PATHOGENS - ABSTRACT INCREASING ANTIBIOTIC RESISTANCE NECESSITATES EXPANDING RESEARCH INTO THE MECHANISMS BY $733,500
2026National Institutes of HealthGrant or other assistanceDIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847CONTROL OF LIPOGENESIS AND HEPATIC STEATOSIS BY CASPASE-2$722,374
2026National Institutes of HealthGrant or other assistanceCANCER BIOLOGY RESEARCH 93.396A NEW MOUSE MODEL FOR STUDYING THE PATHOGENESIS AND IMMUNOBIOLOGY OF INTRAHEPATIC CHOLANGIOCARCINOMA AND IMPROVING ITS IMMUNOTHERAPY - ABSTRACT INTRAHEPATIC CHO$695,955
2026National Institutes of HealthGrant or other assistanceEXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853DETERMINING THE STOICHIOMETRY OF ENDOGENOUS VOLTAGE-GATED POTASSIUM CHANNELS IN THE BRAIN - PROJECT SUMMARY FOR NEURONS TO ACT AS THE BASIC UNIT OF INFORMATION $670,380
2026National Institutes of HealthGrant or other assistanceDIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847DISSECTING THE INTRACELLULAR AND EXTRACELLULAR ROLE OF TREM2 IN THE PATHOGENESIS OF NON-ALCOHOLIC STEATOHEPATITIS. - ABSTRACT: NON-ALCOHOLIC STEATOHEPATITIS (NA$664,854
2026National Institutes of HealthGrant or other assistanceCANCER TREATMENT RESEARCH 93.395TRANSCRIPTIONAL REPROGRAMMING OF ANTI-TUMOR IMMUNITY - PROJECT SUMMARY IMMUNE CHECKPOINT BLOCKADE THERAPIES HAVE GARNERED EXCITEMENT DUE TO THEIR ABILITY TO IND$646,134
2026National Institutes of HealthGrant or other assistanceCANCER TREATMENT RESEARCH 93.395DISCOVERY OF NOVEL INHIBITORS TARGETING TRANS-GOLGI NETWORK ACIDIFICATION IN PANCREATIC CANCER - PROJECT SUMMARY PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) IS PRO$645,540
2026National Institutes of HealthGrant or other assistanceEXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853INVESTIGATION OF ECDNA AS A DRIVER OF INTRATUMORAL HETEROGENEITY AND TREATMENT RESISTANCE IN HIGH-RISK MEDULLOBLASTOMA - THE OVERALL OBJECTIVE OF THIS PROPOSAL $636,772
2026National Institutes of HealthGrant or other assistanceBIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859SPECTRAL CELL SORTER - PROJECT SUMMARY/ABSTRACT THIS S10 APPLICATION REQUESTS A CYTEK AURORA CS SPECTRAL CELL SORTER FOR SANFORD BURNHAM PREBYS (SBP) TO REPLACE$632,113
2026National Institutes of HealthGrant or other assistanceTRANS-NIH RESEARCH SUPPORT 93.310SPATIAL MAPPING SENESCENT CELLS ACROSS THE MOUSE LIFESPAN BY MULTIPLEX TRANSCRIPTOMICS AND EPIGENOMICS - PROJECT SUMMARY CELLULAR SENESCENCE, CHARACTERIZED BY S$630,884
2026National Institutes of HealthGrant or other assistanceCANCER BIOLOGY RESEARCH 93.396EPHA2 RECEPTOR SIGNALING IN BREAST CANCER MECHANOTRANSDUCTION - SUMMARY MECHANICAL FORCES GENERATED BY A RIGID EXTRACELLULAR MATRIX (ECM) IN THE TUMOR MICROENVI$623,932
2026National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866HORMETIC REGULATION OF AUTOPHAGY IN AGING - PROJECT SUMMARY AUTOPHAGY DEGRADES CYTOSOLIC MATERIAL, SUCH AS AGGREGATED PROTEINS, VIA THE FORMATION OF AUTOPHAGOSO$586,599
2026National Institutes of HealthGrant or other assistanceDRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279BRAIN-PENETRANT GPR88 AGONISTS AS NOVEL THERAPEUTICS FOR OPIOID ABUSE - SUMMARY SUBMITTED IN RESPONSE TO RFA-DA-22-031, THIS APPLICATION DESCRIBES A MULTIDISCIP$581,970
2026National Institutes of HealthGrant or other assistanceARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846EPIGENETICS & SIGNALING IN HESC COMMITMENT AND DIFFERENTIATION INTO MUSCLE$581,203
2026National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866MICROGLIAL HEPARAN SULFATE IN THE MODULATION OF APOE FUNCTION AND NEURODEGENERATION - HEPARAN SULFATE (HS), A SULFATED GLYCAN EXPRESSED AT THE CELL SURFACE AND $580,960
2026National Institutes of HealthGrant or other assistanceCANCER TREATMENT RESEARCH 93.395MACROPINOCYTOSIS INHIBITION AS A GLUTAMINE MIMETIC SENSITIZATION STRATEGY IN PANCREATIC CANCER - PROJECT SUMMARY PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) CELLS D$565,933
2026National Institutes of HealthGrant or other assistanceNATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES 93.350TARGETING GATA3 AS A THERAPEUTIC STRATEGY IN TH2-DRIVEN DISEASES - PROJECT SUMMARY ULCERATIVE COLITIS (UC) IS THE MOST COMMON FORM OF INFLAMMATORY BOWEL DISEASE$536,250
2026National Institutes of HealthGrant or other assistanceDIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847UBIQUITIN D AS A POTENTIAL THERAPEUTIC TARGET FOR NASH, HCC AND CHRONIC KIDNEY DISEASES - ABSTRACT: NON-ALCOHOLIC STEATOHEPATITIS (NASH), AN ADVANCED FORM OF NO$500,000
2026National Institutes of HealthGrant or other assistanceCARDIOVASCULAR DISEASES RESEARCH 93.837REGULATION OF BLOOD GLYCOPROTEINS BY LECTIN RECEPTORS IN HEALTH AND DISEASE - SUMMARY THE COMPOSITION OF THE BLOOD PROTEOME PROVIDES INDICATIONS OF NORMAL HEALT$487,500
2026National Institutes of HealthGrant or other assistanceBIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859MOLECULAR MECHANISMS UNDERLYING THE ASSEMBLY OF THE HUMAN PROTEASOME AND ENDOGENOUS PROTEIN COMPLEXES - PROJECT SUMMARY ADVANCES IN STRUCTURAL BIOLOGY TECHNIQUE$487,500
2026National Institutes of HealthGrant or other assistanceDIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847GLYCOSYLTRANSFERASE FUNCTION IN DEVELOPMENT AND DISEASE$487,500
2026National Institutes of HealthGrant or other assistanceBIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859LIGAND FUNCTIONAL SELECTIVITY IN EPHA2 RECEPTOR SIGNALING$476,742
2026National Institutes of HealthGrant or other assistanceCANCER BIOLOGY RESEARCH 93.396MOLECULAR PATHOGENESIS OF AF10-REARRANGED LEUKEMIAS - PROJECT SUMMARY THERE HAS BEEN CONSIDERABLE PROGRESS IN THE LAST FEW YEARS IN THE CHARACTERIZATION OF MOLE$450,287
2026National Institutes of HealthGrant or other assistanceCANCER TREATMENT RESEARCH 93.395TARGETING THE FBXO44/SUV39H1 PATHWAY IN CANCER - PROJECT SUMMARY REPETITIVE ELEMENTS (RES) COMPOSE ~45% OF THE HUMAN GENOME AND ARE NORMALLY TRANSCRIPTIONALLY S$446,063
2026National Institutes of HealthGrant or other assistanceCANCER TREATMENT RESEARCH 93.395TARGETING ER+ BREAST CANCER THROUGH INDUCED VIRAL MIMICRY - PROJECT SUMMARY REPETITIVE ELEMENTS (RES) COMPOSE ~45% OF THE HUMAN GENOME AND ARE NORMALLY TRANSCRI$446,063
2026National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866EPIGENETIC REPROGRAMMING TO COUNTERACT NEURONAL AGING AND DEGENERATION - PROJECT SUMMARY/ABSTRACT THE AGING BRAIN IS INCREASINGLY SUSCEPTIBLE TO COGNITIVE DECLI$248,999
2026National Institutes of HealthGrant or other assistanceCANCER TREATMENT RESEARCH 93.395IMMUNE CHECKPOINT BLOCKADE TARGETING THE NOVEL PSGL-1/VISTA AXIS FOR PANCREATIC CANCER - PROJECT SUMMARY THE GOAL OF THIS PROJECT IS TO DEVELOP A NOVEL IMMUNOTH$209,674
2026National Institutes of HealthGrant or other assistanceCANCER BIOLOGY RESEARCH 93.396DEVELOPMENT AND IMPLEMENTATION OF ADVANCED TECHNOLOGIES FOR CANCER METABOLISM RESEARCH - PROJECT SUMMARY THIS PROPOSAL REQUESTS SUPPORT FOR MY POSITION AS THE D$142,032
2026Defense Health AgencyGrant or other assistanceMILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420TARGETING GLIOBLASTOMA WITH A FIRST-IN-CLASS BRD8 MOLECULAR GLUE DEGRADER AND TEMOZOLOMIDE$140,000
2026National Institutes of HealthGrant or other assistanceCANCER RESEARCH MANPOWER 93.398ROLE OF P2X4 RECEPTORS IN GOLGI PH REGULATION IN PANCREATIC CANCER - PROJECT SUMMARY PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) IS AMONG THE MOST LETHAL CANCERS, I$46,714
2026National Institutes of HealthGrant or other assistanceCANCER RESEARCH MANPOWER 93.398PIKFYVE REGULATES PH HOMEOSTASIS AND TUMOR GROWTH IN PANCREATIC CANCER - PROJECT SUMMARY THE CURRENT OVERALL 5-YEAR SURVIVAL RATE FOR PANCREATIC DUCTAL ADENOCAR$41,386
2026National Institutes of HealthGrant or other assistanceCARDIOVASCULAR DISEASES RESEARCH 93.837ETS TRANSCRIPTION FACTORS AS CARDIAC MAINTENANCE REGULATORS: LINKING RAF-ERK-PNT SIGNALING TO ADULT CARDIAC HYPERTROPHY - PROJECT SUMMARY HYPERTROPHIC CARDIOMYO$38,314
2026National Institutes of HealthGrant or other assistanceCANCER TREATMENT RESEARCH 93.395DISCOVERY OF GLUTARYL-COA DEHYDROGENASE INHIBITORS FOR MELANOMA AND PANCREATIC CANCER - PROJECT SUMMARY MELANOMA IS AN EXTREMELY AGGRESSIVE CANCER WITH HIGH MOR$0
2026Defense Health AgencyGrant or other assistanceMILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420THERAPEUTIC TARGETING OF A LIPID KINASE REGULATOR OF MUTANT P53 IN BREAST CANCER$0
2026National Institutes of HealthGrant or other assistanceCARDIOVASCULAR DISEASES RESEARCH 93.837DISCOVERY OF SMALL MOLECULE REGULATORS OF ATRIAL CARDIOMYOCYTE ACTION POTENTIAL DURATION TO RESTORE NORMAL CARDIAC RHYTHM IN ATRIAL FIBRILLATION - PROJECT SUMMA$0
2026National Institutes of HealthGrant or other assistanceALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855PROTEIN SIALYLATION AND DE-SIALYATION IN CELL SURFACE GLYCOPROTEIN HOMEOSTASIS AND DISEASE - SUMMARY PROTEIN SIALYLATION IS A POST-TRANSLATIONAL MODIFICATION PR$0
2026National Institutes of HealthGrant or other assistanceEXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853SPATIAL REGULATORS OF SKELETAL MUSCLE REGENERATION AND DISEASE - SKELETAL MUSCLES ARE RESPONSIBLE FOR MOVEMENT, BREATHING, POSTURE AND METABOLISM. LOSS OF MUSCL-$20
2026National Institutes of HealthGrant or other assistanceDRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279CLINICAL DEVELOPMENT OF AN MGLU2 POSITIVE ALLOSTERIC MODULATOR TO TREAT NICOTINE ADDICTION-$214
2026National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866PRECLINICAL DISCOVERY OF NOVEL FARNESYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND RELATED TAUOPATHIES - PROJECT SUMMARY ALZHEIMER’S DI-$368
2026National Institutes of HealthGrant or other assistanceTRANS-NIH RESEARCH SUPPORT 93.310TRANSFORMATIVE RESEARCH ON SOMATIC GENE RECOMBINATION IN THE NORMAL AND ALZHEIMER'S DISEASE-RELATED DEMENTIA BRAIN-$1,448
2026National Institutes of HealthGrant or other assistanceCARDIOVASCULAR DISEASES RESEARCH 93.837PROTEIN GLYCOSYLATION IN THE COAGULOPATHY AND INFLAMMATION OF SEPSIS-$3,021
2026National Institutes of HealthGrant or other assistanceALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855OVERRIDING THE IMMUNE EVASION TACTICS OF CORONAVIRUS-$6,095
2026National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866ALTERED REVERSE TRANSCRIPTASE-DEPENDENT GENE DIVERSIFICATION MECHANISMS IN ALZHEIMER'S DISEASE BRAINS-$13,983
2026National Institutes of HealthGrant or other assistanceCARDIOVASCULAR DISEASES RESEARCH 93.837OPTIMIZATION OF FIBROBLAST-SELECTIVE INHIBITORS OF YAP/TAZ AS NOVEL THERAPEUTICS FOR PULMONARY FIBROSIS - PROJECT SUMMARY IDIOPATHIC PULMONARY FIBROSIS IS A CHR-$47,464
2025National Institutes of HealthGrant or other assistanceCANCER CENTERS SUPPORT GRANTS 93.397CANCER CENTER SUPPORT GRANT$4,276,818
2025National Institutes of HealthGrant or other assistanceTRANS-NIH RESEARCH SUPPORT 93.310SPATIAL MAPPING SENESCENT CELLS ACROSS THE MOUSE LIFESPAN BY MULTIPLEX TRANSCRIPTOMICS AND EPIGENOMICS - PROJECT SUMMARY CELLULAR SENESCENCE, CHARACTERIZED BY S$2,889,150
2025National Institutes of HealthGrant or other assistanceCARDIOVASCULAR DISEASES RESEARCH 93.837PROTEIN GLYCOSYLATION IN THE COAGULOPATHY AND INFLAMMATION OF SEPSIS$2,674,150
2025National Institutes of HealthGrant or other assistanceDRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279SAFETY/TOXICOLOGY, ADME AND CMC ACTIVITIES TO SUPPORT THE ASSESSMENT OF THE MGLU2 PAM SBP-9330 IN A PHASE 2 CLINICAL STUDY IN SMOKERS - PROJECT SUMMARY THIS RES$2,652,771
2025National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866AGING AS A RISK FACTOR AND TARGET FOR PREVENTION OF LIVER CANCER - PROJECT SUMMARY – OVERALL THE INCIDENCES OF LIVER CANCER (PRIMARILY HEPATOCELLULAR CARCINOMA $2,530,091
2025National Institutes of HealthGrant or other assistanceCANCER BIOLOGY RESEARCH 93.396ROLE OF HYPERNUTRITION AND METABOLIC STRESS IN NON-ALCOHOLIC STEATOHEPATITIS (NASH) DRIVEN HEPATOCELLULAR CARCINOMA (HCC) - PROJECT SUMMARY – OVERALL HEPATOCELL$2,302,833
2025National Institutes of HealthGrant or other assistanceCANCER BIOLOGY RESEARCH 93.396REGULATION OF PDAC METABOLISM AND IMMUNITY BY COLLAGEN AND ITS CLEAVAGE PRODUCTS - ABSTRACT PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) IS A HIGHLY DESMOPLASTIC AND$1,262,768
2025Defense Health AgencyGrant or other assistanceMILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420A CHEMICAL ENGINEERING APPROACH TO ALS THAT AMPLIFIES A MORE SOPHISTICATED VIEW OF THE MULTIMODAL THERAPEUTIC ACTIONS OF DONOR AND HOST NEURAL STEM CELLS IN THA$1,078,882
2025National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866ELUCIDATING A MICROGLIAASSOCIATED ROLE FOR SORLA IN MODULATING AD PATHOGENESIS - PROJECT SUMMARY MUTATIONS IN SORLA (ENCODED BY SORL1) IDENTIFIED THROUGH GWAS $867,404
2025National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866PRECLINICAL DISCOVERY OF NOVEL FARNESYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND RELATED TAUOPATHIES - PROJECT SUMMARY ALZHEIMER’S DI$857,439
2025National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866NOVEL NEUROPROTECTIVE ROLES FOR THE ALZHEIMER'S DISEASE RISK GENE SORLA IN TAU PATHOLOGY AND PATHOGENESIS - NUMEROUS MUTATIONAL VARIANTS IN THE SORLA (SORL1) GE$846,520
2025National Institutes of HealthGrant or other assistanceDIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847NEW CONGENITAL DISORDERS OF GLYCOSYLATION: THERAPY AND MODELS$809,568
2025National Institutes of HealthGrant or other assistanceCANCER TREATMENT RESEARCH 93.395DISCOVERY OF POTENT SELECTIVE INHIBITORS OF THE HISTONE METHYLTRANSFERASE SUV39H1 FOR THE TREATMENT OF CANCER - PROJECT SUMMARY CANCER TREATMENT HAS BEEN TRANSF$809,248
2025National Institutes of HealthGrant or other assistanceALCOHOL RESEARCH PROGRAMS 93.273OPTIMIZATION OF DRUG-LIKE PROPERTIES OF CRFBP-CRF2 NEGATIVE ALLOSTERIC MODULATORS FOR ALCOHOL USE DISORDER - PROJECT SUMMARY THIS APPLICATION, “OPTIMIZATION OF $786,961
2025National Institutes of HealthGrant or other assistanceCANCER TREATMENT RESEARCH 93.395SCREENING FOR INHIBITORS OF THE CHROMATIN READER SGF29 - PROJECT SUMMARY AML IS A DEVASTATING DISEASE WITH SURVIVAL RATES OF ONLY 30-35 PERCENT AND CURE-RATES H$768,437
2025National Institutes of HealthGrant or other assistanceDIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847IMPROVING PROINSULIN FOLDING TO AMELIORATE TYPE II DIABETES - PROJECT SUMMARY DIABETES IS AMONG THE FASTEST GROWING HEALTH CHALLENGES OF THE 21ST CENTURY, AFFEC$760,498
2025National Institutes of HealthGrant or other assistanceALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855COMPARATIVE RESISTOMICS OF GRAM-NEGATIVE BACTERIAL PATHOGENS - ABSTRACT INCREASING ANTIBIOTIC RESISTANCE NECESSITATES EXPANDING RESEARCH INTO THE MECHANISMS BY $733,500
2025National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866DISCOVERY AND OPTIMIZATION OF APOE4 CORRECTORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE - PROJECT SUMMARY ALZHEIMER'S DISEASE (AD) IS A MAJOR PUBLIC HEALTH CRIS$689,010
2025National Institutes of HealthGrant or other assistanceCANCER BIOLOGY RESEARCH 93.396REWIRING T CELL EXHAUSTION WITH IMMUNE CHECKPOINT BLOCKADE THERAPY - PROJECT SUMMARY THE GOAL OF THIS PROJECT IS TO DETERMINE WHETHER IT IS POSSIBLE TO PROMOTE $674,996
2025National Institutes of HealthGrant or other assistanceDIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847DISSECTING THE INTRACELLULAR AND EXTRACELLULAR ROLE OF TREM2 IN THE PATHOGENESIS OF NON-ALCOHOLIC STEATOHEPATITIS. - ABSTRACT: NON-ALCOHOLIC STEATOHEPATITIS (NA$665,028
2025National Institutes of HealthGrant or other assistanceCANCER TREATMENT RESEARCH 93.395DISCOVERY OF NOVEL INHIBITORS TARGETING TRANS-GOLGI NETWORK ACIDIFICATION IN PANCREATIC CANCER - PROJECT SUMMARY PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) IS PRO$645,331
2025National Institutes of HealthGrant or other assistanceDRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279BRAIN-PENETRANT GPR88 AGONISTS AS NOVEL THERAPEUTICS FOR OPIOID ABUSE - SUMMARY SUBMITTED IN RESPONSE TO RFA-DA-22-031, THIS APPLICATION DESCRIBES A MULTIDISCIP$644,048
2025National Institutes of HealthGrant or other assistanceEXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853INVESTIGATION OF ECDNA AS A DRIVER OF INTRATUMORAL HETEROGENEITY AND TREATMENT RESISTANCE IN HIGH-RISK MEDULLOBLASTOMA - THE OVERALL OBJECTIVE OF THIS PROPOSAL $636,772
2025National Institutes of HealthGrant or other assistanceCANCER BIOLOGY RESEARCH 93.396EPHA2 RECEPTOR SIGNALING IN BREAST CANCER MECHANOTRANSDUCTION - SUMMARY MECHANICAL FORCES GENERATED BY A RIGID EXTRACELLULAR MATRIX (ECM) IN THE TUMOR MICROENVI$623,123
2025National Institutes of HealthGrant or other assistanceARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846MECHANISMS THAT COUPLE IRREGULAR DEVELOPMENT OF FETAL MELANOBLASTS TO PREMATURE EXHAUSTION OF ADULT MELANOCYTE STEM CELLS - PROJECT SUMMARY MAINTENANCE OF TISSU$619,779
2025National Institutes of HealthGrant or other assistanceARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846ROLE OF FBXW7-MEDIATED PROTEASOMAL DEGRADATION IN MYOFIBERS IN DETERMINING MUSCLE STEM CELL POOL SIZE$586,260
2025National Institutes of HealthGrant or other assistanceCANCER BIOLOGY RESEARCH 93.396REGULATION AND FUNCTION OF STROMAL MACROPINOCYTOSIS IN PANCREATIC DUCTAL ADENOCARCINOMA - PROJECT SUMMARY RECENT YEARS HAVE WITNESSED AN APPRECIATION OF THE ROL$585,801
2025National Institutes of HealthGrant or other assistanceARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846EPIGENETICS & SIGNALING IN HESC COMMITMENT AND DIFFERENTIATION INTO MUSCLE$575,324
2025National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866HORMETIC REGULATION OF AUTOPHAGY IN AGING - PROJECT SUMMARY AUTOPHAGY DEGRADES CYTOSOLIC MATERIAL, SUCH AS AGGREGATED PROTEINS, VIA THE FORMATION OF AUTOPHAGOSO$574,868
2025National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866MICROGLIAL HEPARAN SULFATE IN THE MODULATION OF APOE FUNCTION AND NEURODEGENERATION - HEPARAN SULFATE (HS), A SULFATED GLYCAN EXPRESSED AT THE CELL SURFACE AND $569,341
2025National Institutes of HealthGrant or other assistanceCANCER TREATMENT RESEARCH 93.395MACROPINOCYTOSIS INHIBITION AS A GLUTAMINE MIMETIC SENSITIZATION STRATEGY IN PANCREATIC CANCER - PROJECT SUMMARY PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) CELLS D$565,933
2025National Institutes of HealthGrant or other assistanceBIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859FUNCTION AND MECHANISM OF THE HIPPO-PI5P4K AXIS FOR GROWTH CONTROL - PROJECT SUMMARY OUR LONG-TERM GOAL IS TO DECIPHER THE MOLECULAR MECHANISMS UNDERLYING PI5P4$555,975
2025National Institutes of HealthGrant or other assistanceCANCER TREATMENT RESEARCH 93.395DISCOVERY OF GLUTARYL-COA DEHYDROGENASE INHIBITORS FOR MELANOMA AND PANCREATIC CANCER - PROJECT SUMMARY MELANOMA IS AN EXTREMELY AGGRESSIVE CANCER WITH HIGH MOR$538,890
2025National Institutes of HealthGrant or other assistanceBIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859A KNOWLEDGE-GUIDED ANALYSIS APPROACH TO RECOVERING RARE SIGNALS FROM SINGLE-CELL TRANSCRIPTOMIC DATA - PROJECT SUMMARY THIS INNOVATIVE PROJECT AIMS AT DEVELOPIN$536,250
2025National Institutes of HealthGrant or other assistanceBIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859LIGAND FUNCTIONAL SELECTIVITY IN EPHA2 RECEPTOR SIGNALING$508,048
2025National Institutes of HealthGrant or other assistanceDIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847UBIQUITIN D AS A POTENTIAL THERAPEUTIC TARGET FOR NASH, HCC AND CHRONIC KIDNEY DISEASES - ABSTRACT: NON-ALCOHOLIC STEATOHEPATITIS (NASH), AN ADVANCED FORM OF NO$500,000
2025National Institutes of HealthGrant or other assistanceDIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847GLYCOSYLTRANSFERASE FUNCTION IN DEVELOPMENT AND DISEASE$487,500
2025National Institutes of HealthGrant or other assistanceCARDIOVASCULAR DISEASES RESEARCH 93.837REGULATION OF BLOOD GLYCOPROTEINS BY LECTIN RECEPTORS IN HEALTH AND DISEASE - SUMMARY THE COMPOSITION OF THE BLOOD PROTEOME PROVIDES INDICATIONS OF NORMAL HEALT$487,500
2025National Institutes of HealthGrant or other assistanceBIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859MOLECULAR MECHANISMS UNDERLYING THE ASSEMBLY OF THE HUMAN PROTEASOME AND ENDOGENOUS PROTEIN COMPLEXES - PROJECT SUMMARY ADVANCES IN STRUCTURAL BIOLOGY TECHNIQUE$487,500
2025National Institutes of HealthGrant or other assistanceALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855PROTEIN SIALYLATION AND DE-SIALYATION IN CELL SURFACE GLYCOPROTEIN HOMEOSTASIS AND DISEASE - SUMMARY PROTEIN SIALYLATION IS A POST-TRANSLATIONAL MODIFICATION PR$472,875
2025National Institutes of HealthGrant or other assistanceCANCER BIOLOGY RESEARCH 93.396REGULATION OF NUTRIENT STRESS-INDUCED MACROPINOCYTOSIS IN PANCREATIC DUCTAL ADENOCARCINOMA$466,136
2025National Institutes of HealthGrant or other assistanceCANCER BIOLOGY RESEARCH 93.396MOLECULAR PATHOGENESIS OF AF10-REARRANGED LEUKEMIAS - PROJECT SUMMARY THERE HAS BEEN CONSIDERABLE PROGRESS IN THE LAST FEW YEARS IN THE CHARACTERIZATION OF MOLE$449,276
2025National Institutes of HealthGrant or other assistanceCANCER TREATMENT RESEARCH 93.395TARGETING THE FBXO44/SUV39H1 PATHWAY IN CANCER - PROJECT SUMMARY REPETITIVE ELEMENTS (RES) COMPOSE ~45% OF THE HUMAN GENOME AND ARE NORMALLY TRANSCRIPTIONALLY S$446,063
2025National Institutes of HealthGrant or other assistanceCANCER TREATMENT RESEARCH 93.395TARGETING ER+ BREAST CANCER THROUGH INDUCED VIRAL MIMICRY - PROJECT SUMMARY REPETITIVE ELEMENTS (RES) COMPOSE ~45% OF THE HUMAN GENOME AND ARE NORMALLY TRANSCRI$446,063
2025National Institutes of HealthGrant or other assistanceDIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847AUGMENTED NOTCH SIGNALING AS A THERAPEUTIC APPROACH FOR ALAGILLE SYNDROME - PROJECT SUMMARY ALAGILLE SYNDROME (ALGS) IS AN AUTOSOMAL DOMINANT DISORDER CHARACTER$433,179
2025National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866CYTOPLASMIC CHROMATIN FRAGMENTS IN CELL SENESCENCE - NOVEL MECHANISMS AND INTERVENTIONS - PROJECT SUMMARY CELLULAR SENESCENCE IS A CAUSE OF CELL AND TISSUE AGIN$419,931
2025National Institutes of HealthGrant or other assistanceCARDIOVASCULAR DISEASES RESEARCH 93.837IDENTIFICATION OF MICROPROTEINS ASSOCIATED WITH HEMATOPOIESIS AND RELATED DISEASES - PROJECT SUMMARY THIS INNOVATIVE, INTER-DISCIPLINARY PROJECT AIMS AT DISCOVE$292,500
2025National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866THE AGING PANCREAS AS A PRO-TUMORIGENIC NICHE - PROJECT SUMMARY AGE IS A MAJOR RISK FACTOR FOR PANCREATIC DUCTAL ADENOCARCINOMA (PDAC), WITH THE INCIDENCE OF PD$292,500
2025National Institutes of HealthGrant or other assistanceCANCER TREATMENT RESEARCH 93.395IMMUNE CHECKPOINT BLOCKADE TARGETING THE NOVEL PSGL-1/VISTA AXIS FOR PANCREATIC CANCER - PROJECT SUMMARY THE GOAL OF THIS PROJECT IS TO DEVELOP A NOVEL IMMUNOTH$268,345
2025National Institutes of HealthGrant or other assistanceEXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853SPATIAL REGULATORS OF SKELETAL MUSCLE REGENERATION AND DISEASE - SKELETAL MUSCLES ARE RESPONSIBLE FOR MOVEMENT, BREATHING, POSTURE AND METABOLISM. LOSS OF MUSCL$248,721
2025National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866EPIGENETIC REPROGRAMMING TO COUNTERACT NEURONAL AGING AND DEGENERATION - PROJECT SUMMARY/ABSTRACT THE AGING BRAIN IS INCREASINGLY SUSCEPTIBLE TO COGNITIVE DECLI$244,019
2025Defense Health AgencyGrant or other assistanceMILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420FUNCTION AND THERAPEUTIC POTENTIAL OF R LOOPS IN GLIOBLASTOMA$195,000
2025National Institutes of HealthGrant or other assistanceCANCER BIOLOGY RESEARCH 93.396DEVELOPMENT AND IMPLEMENTATION OF ADVANCED TECHNOLOGIES FOR CANCER METABOLISM RESEARCH - PROJECT SUMMARY THIS PROPOSAL REQUESTS SUPPORT FOR MY POSITION AS THE D$142,032
2025National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866FRAGMENT-BASED DISCOVERY OF STEP MODULATORS IN ALZHEIMER'S DISEASE ADMINISTRATIVE SUPPLEMENT - PROJECT SUMMARY STRIATAL-ENRICHED TYROSINE PHOSPHATASE (STEP) IS $111,976
2025National Institutes of HealthGrant or other assistanceCANCER RESEARCH MANPOWER 93.398PIKFYVE REGULATES PH HOMEOSTASIS AND TUMOR GROWTH IN PANCREATIC CANCER - PROJECT SUMMARY THE CURRENT OVERALL 5-YEAR SURVIVAL RATE FOR PANCREATIC DUCTAL ADENOCAR$40,810
2025National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866EPIGENETIC DRIFT OF THE AGING HEART IN DROSOPHILA - PROJECT SUMMARY AGING IS A COMPLEX PROCESS ACCOMPANIED BY LOSS OF PROTEOSTASIS, GENOMIC INSTABILITY, DEREGUL$0
2025National Institutes of HealthGrant or other assistanceALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855CHARACTERIZING THE NUCLEAR PORE COMPLEX-T CELL RECEPTOR CONNECTION$0
2025Defense Health AgencyGrant or other assistanceMILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420DOES DYSTROPHIN RESTORATION REVERSE EPIGENETIC AND TRANSCRIPTIONAL PATHOGENIC FEATURES IN DUCHENNE MUSCULAR DYSTROPHY?$0
2025National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866TARGETING NEUROINFLAMMATION IN AD WITH NOVEL CX3CR1 AGONISTS-$288
2025National Institutes of HealthGrant or other assistanceTRANS-NIH RESEARCH SUPPORT 93.310DEFINING CHROMOSTASIS - A CANDIDATE REGULATOR OF HEALTHY AGING AND LONGEVITY-$304
2025National Institutes of HealthGrant or other assistanceORAL DISEASES AND DISORDERS RESEARCH 93.121EXPLORATORY THERAPY FOR THE SKELETAL/DENTAL PHENOTYPE IN PHOSPHO1 DEFICIENCY - +:DDF6 ?@?DA64:7:4 2=<2=:?6 A9@DA92E2D6 +&( 2?5 ( '*( ' 2C6 EH@ >2EC:I G6D:4=6D %-$920
2025National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866A NOVEL ROLE FOR THE UPR COMPONENT, ATF6 IN AD-ASSOCIATED NEUROPROTECTIVE PATHWAYS-$2,407
2025National Institutes of HealthGrant or other assistanceRESEARCH INFRASTRUCTURE PROGRAMS 93.351BECKMAN COULTER BIOMEK I7 HYBRID AUTOMATED WORKSTATION - PROJECT SUMMARY SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE (SBP) HAS 40 RESEARCH LABS SPECIALIZ-$8,737
2025National Institutes of HealthGrant or other assistanceCANCER CAUSE AND PREVENTION RESEARCH 93.393THE ROLE OF THE CCR4-NOT COMPLEX IN THE REGULATION OF NUCLEAR PORE COMPLEX ASSEMBLY - PROJECT SUMMARY CANCER CONTINUES TO BE A LEADING CAUSE OF DEATH WORLDWIDE-$11,169
2025National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866NEW DOWN SYNDROME BRAIN ORGANIZATION REVEALED BY SINGLE-CELL GENOMICS - PROJECT SUMMARY/ABSTRACT NEARLY 100% OF DOWN SYNDROME (DS; TRISOMY OF HUMAN CHROMOSOME 2-$14,012
2025National Aeronautics and Space AdministrationGrant or other assistanceSCIENCE 43.001OUR STUDIES WILL USE THE FRUIT FLY DROSOPHILA AND THE WORM C. ELEGANS TO IDENTIFY CONSERVED MECHANISMS UNDERLYING THE OXIDATIVE STRESS RESPONSE TO ALTERED GRA-$20,000
2025National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866DISCOVERY AND DEVELOPMENT OF APOE4 CORRECTORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE - PROJECT SUMMARY ALZHEIMER'S DISEASE (AD) IS A MAJOR PUBLIC HEALTH CRISI-$34,740
2025National Institutes of HealthGrant or other assistanceCANCER RESEARCH MANPOWER 93.398CANCER TARGETS AND DRUG DISCOVERY-$92,536
2024National Institutes of HealthGrant or other assistanceCANCER CENTERS SUPPORT GRANTS 93.397CANCER CENTER SUPPORT GRANT$4,081,820
2024National Institutes of HealthGrant or other assistanceDRUG ABUSE AND ADDICTION RESEARCH PROGRAMS 93.279SAFETY/TOXICOLOGY, ADME AND CMC ACTIVITIES TO SUPPORT THE ASSESSMENT OF THE MGLU2 PAM SBP-9330 IN A PHASE 2 CLINICAL STUDY IN SMOKERS - PROJECT SUMMARY THIS RES$3,331,239
2024National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866FRAGMENT-BASED DISCOVERY OF STEP MODULATORS IN ALZHEIMER'S DISEASE ADMINISTRATIVE SUPPLEMENT - PROJECT SUMMARY STRIATAL-ENRICHED TYROSINE PHOSPHATASE (STEP) IS $2,835,382
2024National Institutes of HealthGrant or other assistanceTRANS-NIH RESEARCH SUPPORT 93.310SPATIAL MAPPING SENESCENT CELLS ACROSS THE MOUSE LIFESPAN BY MULTIPLEX TRANSCRIPTOMICS AND EPIGENOMICS - PROJECT SUMMARY CELLULAR SENESCENCE, CHARACTERIZED BY S$2,690,250
2024National Institutes of HealthGrant or other assistanceCARDIOVASCULAR DISEASES RESEARCH 93.837PROTEIN GLYCOSYLATION IN THE COAGULOPATHY AND INFLAMMATION OF SEPSIS$2,622,490
2024National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866AGING AS A RISK FACTOR AND TARGET FOR PREVENTION OF LIVER CANCER - PROJECT SUMMARY – OVERALL THE INCIDENCES OF LIVER CANCER (PRIMARILY HEPATOCELLULAR CARCINOMA $2,585,444
2024National Institutes of HealthGrant or other assistanceCANCER BIOLOGY RESEARCH 93.396ROLE OF HYPERNUTRITION AND METABOLIC STRESS IN NON-ALCOHOLIC STEATOHEPATITIS (NASH) DRIVEN HEPATOCELLULAR CARCINOMA (HCC) - PROJECT SUMMARY – OVERALL HEPATOCELL$2,397,277
2024National Institutes of HealthGrant or other assistanceDRUG ABUSE AND ADDICTION RESEARCH PROGRAMS 93.279DEVELOPMENT OF SBI-553, AN ALLOSTERIC MODULATOR OF NTR1, FOR THE TREATMENT OF SUBSTANCE USE DISORDERS - PROJECT SUMMARY OPIOID USE DISORDER (OUD) IS A MAJOR PUB$1,348,795
2024National Institutes of HealthGrant or other assistanceCANCER BIOLOGY RESEARCH 93.396REWIRED SIGNALING AT THE NEXUS OF MELANOMA METASTASIS AND RESISTANCE - SUMMARY THIS R35 FOCUSES ON NOVEL MECHANISMS UNDERLYING CONTROL OF KEY UPR COMPONENTS THA$1,170,000
2024National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866ALTERED REVERSE TRANSCRIPTASE-DEPENDENT GENE DIVERSIFICATION MECHANISMS IN ALZHEIMER'S DISEASE BRAINS$929,705
2024National Institutes of HealthGrant or other assistanceTRANS-NIH RESEARCH SUPPORT 93.310TRANSFORMATIVE RESEARCH ON SOMATIC GENE RECOMBINATION IN THE NORMAL AND ALZHEIMER'S DISEASE-RELATED DEMENTIA BRAIN$924,514
2024National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866DISCOVERY AND OPTIMIZATION OF APOE4 CORRECTORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE - PROJECT SUMMARY ALZHEIMER'S DISEASE (AD) IS A MAJOR PUBLIC HEALTH CRIS$919,106
2024National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866DISCOVERY AND DEVELOPMENT OF APOE4 CORRECTORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE - PROJECT SUMMARY ALZHEIMER'S DISEASE (AD) IS A MAJOR PUBLIC HEALTH CRISI$881,443
2024National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866PRECLINICAL DISCOVERY OF NOVEL FARNESYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND RELATED TAUOPATHIES - PROJECT SUMMARY ALZHEIMER’S DI$878,176
2024National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866NOVEL NEUROPROTECTIVE ROLES FOR THE ALZHEIMER'S DISEASE RISK GENE SORLA IN TAU PATHOLOGY AND PATHOGENESIS - NUMEROUS MUTATIONAL VARIANTS IN THE SORLA (SORL1) GE$867,695
2024National Institutes of HealthGrant or other assistanceCARDIOVASCULAR DISEASES RESEARCH 93.837GENETIC CONTROL OF THE HEART BY TINMAN AND NEUROMANCER$822,148
2024National Institutes of HealthGrant or other assistanceDIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847NEW CONGENITAL DISORDERS OF GLYCOSYLATION: THERAPY AND MODELS$809,566
2024National Institutes of HealthGrant or other assistanceCANCER TREATMENT RESEARCH 93.395DISCOVERY OF POTENT SELECTIVE INHIBITORS OF THE HISTONE METHYLTRANSFERASE SUV39H1 FOR THE TREATMENT OF CANCER - PROJECT SUMMARY CANCER TREATMENT HAS BEEN TRANSF$809,234
2024National Institutes of HealthGrant or other assistanceALCOHOL RESEARCH PROGRAMS 93.273OPTIMIZATION OF DRUG-LIKE PROPERTIES OF CRFBP-CRF2 NEGATIVE ALLOSTERIC MODULATORS FOR ALCOHOL USE DISORDER - PROJECT SUMMARY THIS APPLICATION, “OPTIMIZATION OF $800,043
2024National Institutes of HealthGrant or other assistanceMENTAL HEALTH RESEARCH GRANTS 93.242A PHARMACOCHAPERONE-BASED STRATEGY FOR IDENTIFYING CHEMICAL PROBES OF BRAIN-DERIVED ORPHAN GPCRS$785,074
2024National Aeronautics and Space AdministrationGrant or other assistanceSCIENCE 43.001OUR STUDIES WILL USE THE FRUIT FLY DROSOPHILA AND THE WORM C. ELEGANS TO IDENTIFY CONSERVED MECHANISMS UNDERLYING THE OXIDATIVE STRESS RESPONSE TO ALTERED GRA$767,134
2024National Institutes of HealthGrant or other assistanceALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855COMPARATIVE RESISTOMICS OF GRAM-NEGATIVE BACTERIAL PATHOGENS - ABSTRACT INCREASING ANTIBIOTIC RESISTANCE NECESSITATES EXPANDING RESEARCH INTO THE MECHANISMS BY $733,500
2024National Institutes of HealthGrant or other assistanceDIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847IMPROVING PROINSULIN FOLDING TO AMELIORATE TYPE II DIABETES - PROJECT SUMMARY DIABETES IS AMONG THE FASTEST GROWING HEALTH CHALLENGES OF THE 21ST CENTURY, AFFEC$730,079
2024National Institutes of HealthGrant or other assistanceCANCER BIOLOGY RESEARCH 93.396GCDH ADDICTION IN MELANOMA - PROJECT SUMMARY IN THIS REVISED R01 APPLICATION WE PROPOSE TO CHARACTERIZE A NOVEL MECHANISM UNDERLYING THE CONTROL OF APOPTOSIS BY$699,580
2024Defense Health AgencyGrant or other assistanceMILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420SELECTIVE TARGETING OF MUTANT SHP2 ONCOPROTEINS IN RARE LEUKEMIAS$682,472
2024National Institutes of HealthGrant or other assistanceARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846MECHANISMS THAT COUPLE IRREGULAR DEVELOPMENT OF FETAL MELANOBLASTS TO PREMATURE EXHAUSTION OF ADULT MELANOCYTE STEM CELLS - PROJECT SUMMARY MAINTENANCE OF TISSU$676,107
2024National Institutes of HealthGrant or other assistanceCANCER BIOLOGY RESEARCH 93.396REWIRING T CELL EXHAUSTION WITH IMMUNE CHECKPOINT BLOCKADE THERAPY - PROJECT SUMMARY THE GOAL OF THIS PROJECT IS TO DETERMINE WHETHER IT IS POSSIBLE TO PROMOTE $674,996
2024National Institutes of HealthGrant or other assistanceDIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847DISSECTING THE INTRACELLULAR AND EXTRACELLULAR ROLE OF TREM2 IN THE PATHOGENESIS OF NON-ALCOHOLIC STEATOHEPATITIS. - ABSTRACT: NON-ALCOHOLIC STEATOHEPATITIS (NA$661,236
2024National Institutes of HealthGrant or other assistanceALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855CHARACTERIZING THE NUCLEAR PORE COMPLEX-T CELL RECEPTOR CONNECTION$653,587
2024National Institutes of HealthGrant or other assistanceARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846EPIGENETICS & SIGNALING IN HESC COMMITMENT AND DIFFERENTIATION INTO MUSCLE$636,717
2024National Institutes of HealthGrant or other assistanceARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846ROLE OF FBXW7-MEDIATED PROTEASOMAL DEGRADATION IN MYOFIBERS IN DETERMINING MUSCLE STEM CELL POOL SIZE$631,857
2024National Institutes of HealthGrant or other assistanceCANCER BIOLOGY RESEARCH 93.396EPHA2 RECEPTOR SIGNALING IN BREAST CANCER MECHANOTRANSDUCTION - SUMMARY MECHANICAL FORCES GENERATED BY A RIGID EXTRACELLULAR MATRIX (ECM) IN THE TUMOR MICROENVI$620,121
2024National Institutes of HealthGrant or other assistanceEXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853INVESTIGATION OF ECDNA AS A DRIVER OF INTRATUMORAL HETEROGENEITY AND TREATMENT RESISTANCE IN HIGH-RISK MEDULLOBLASTOMA - THE OVERALL OBJECTIVE OF THIS PROPOSAL $617,669
2024National Institutes of HealthGrant or other assistanceCANCER TREATMENT RESEARCH 93.395DISCOVERY OF NOVEL INHIBITORS TARGETING TRANS-GOLGI NETWORK ACIDIFICATION IN PANCREATIC CANCER - PROJECT SUMMARY PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) IS PRO$612,825
2024National Institutes of HealthGrant or other assistanceALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855OVERRIDING THE IMMUNE EVASION TACTICS OF CORONAVIRUS$601,563
2024National Institutes of HealthGrant or other assistanceCARDIOVASCULAR DISEASES RESEARCH 93.837OPTIMIZATION OF FIBROBLAST-SELECTIVE INHIBITORS OF YAP/TAZ AS NOVEL THERAPEUTICS FOR PULMONARY FIBROSIS - PROJECT SUMMARY IDIOPATHIC PULMONARY FIBROSIS IS A CHR$596,061
2024National Institutes of HealthGrant or other assistanceRESEARCH INFRASTRUCTURE PROGRAMS 93.351BECKMAN COULTER BIOMEK I7 HYBRID AUTOMATED WORKSTATION - PROJECT SUMMARY SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE (SBP) HAS 40 RESEARCH LABS SPECIALIZ$594,187
2024National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866HORMETIC REGULATION OF AUTOPHAGY IN AGING - PROJECT SUMMARY AUTOPHAGY DEGRADES CYTOSOLIC MATERIAL, SUCH AS AGGREGATED PROTEINS, VIA THE FORMATION OF AUTOPHAGOSO$586,599
2024National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866MICROGLIAL HEPARAN SULFATE IN THE MODULATION OF APOE FUNCTION AND NEURODEGENERATION - HEPARAN SULFATE (HS), A SULFATED GLYCAN EXPRESSED AT THE CELL SURFACE AND $580,960
2024National Institutes of HealthGrant or other assistanceCANCER TREATMENT RESEARCH 93.395DISCOVERY OF GLUTARYL-COA DEHYDROGENASE INHIBITORS FOR MELANOMA AND PANCREATIC CANCER - PROJECT SUMMARY MELANOMA IS AN EXTREMELY AGGRESSIVE CANCER WITH HIGH MOR$577,198
2024Defense Health AgencyGrant or other assistanceMILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420METABOLIC INTERVENTIONS TO HALT PANCREATIC CANCER$571,350
2024National Institutes of HealthGrant or other assistanceCANCER TREATMENT RESEARCH 93.395MACROPINOCYTOSIS INHIBITION AS A GLUTAMINE MIMETIC SENSITIZATION STRATEGY IN PANCREATIC CANCER - PROJECT SUMMARY PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) CELLS D$561,077
2024National Institutes of HealthGrant or other assistanceCANCER BIOLOGY RESEARCH 93.396REGULATION AND FUNCTION OF STROMAL MACROPINOCYTOSIS IN PANCREATIC DUCTAL ADENOCARCINOMA - PROJECT SUMMARY RECENT YEARS HAVE WITNESSED AN APPRECIATION OF THE ROL$556,513
2024National Institutes of HealthGrant or other assistanceBIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859FUNCTION AND MECHANISM OF THE HIPPO-PI5P4K AXIS FOR GROWTH CONTROL - PROJECT SUMMARY OUR LONG-TERM GOAL IS TO DECIPHER THE MOLECULAR MECHANISMS UNDERLYING PI5P4$555,975
2024National Institutes of HealthGrant or other assistanceTRANS-NIH RESEARCH SUPPORT 93.310DEFINING CHROMOSTASIS - A CANDIDATE REGULATOR OF HEALTHY AGING AND LONGEVITY$514,488
2024National Institutes of HealthGrant or other assistanceBIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859MOLECULAR MECHANISMS UNDERLYING THE ASSEMBLY OF THE HUMAN PROTEASOME AND ENDOGENOUS PROTEIN COMPLEXES - PROJECT SUMMARY ADVANCES IN STRUCTURAL BIOLOGY TECHNIQUE$487,500
2024National Institutes of HealthGrant or other assistanceCARDIOVASCULAR DISEASES RESEARCH 93.837REGULATION OF BLOOD GLYCOPROTEINS BY LECTIN RECEPTORS IN HEALTH AND DISEASE - SUMMARY THE COMPOSITION OF THE BLOOD PROTEOME PROVIDES INDICATIONS OF NORMAL HEALT$487,500
2024National Institutes of HealthGrant or other assistanceALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855PROTEIN SIALYLATION AND DE-SIALYATION IN CELL SURFACE GLYCOPROTEIN HOMEOSTASIS AND DISEASE - SUMMARY PROTEIN SIALYLATION IS A POST-TRANSLATIONAL MODIFICATION PR$487,500
2024National Institutes of HealthGrant or other assistanceCARDIOVASCULAR DISEASES RESEARCH 93.837DISCOVERY OF SMALL MOLECULE REGULATORS OF ATRIAL CARDIOMYOCYTE ACTION POTENTIAL DURATION TO RESTORE NORMAL CARDIAC RHYTHM IN ATRIAL FIBRILLATION - PROJECT SUMMA$487,500
2024National Institutes of HealthGrant or other assistanceBIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859LIGAND FUNCTIONAL SELECTIVITY IN EPHA2 RECEPTOR SIGNALING$484,417
2024National Institutes of HealthGrant or other assistanceDIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847UBIQUITIN D AS A POTENTIAL THERAPEUTIC TARGET FOR NASH, HCC AND CHRONIC KIDNEY DISEASES - ABSTRACT: NON-ALCOHOLIC STEATOHEPATITIS (NASH), AN ADVANCED FORM OF NO$480,000
2024National Institutes of HealthGrant or other assistanceDIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847GLYCOSYLTRANSFERASE FUNCTION IN DEVELOPMENT AND DISEASE$468,000
2024National Institutes of HealthGrant or other assistanceCANCER BIOLOGY RESEARCH 93.396REGULATION OF NUTRIENT STRESS-INDUCED MACROPINOCYTOSIS IN PANCREATIC DUCTAL ADENOCARCINOMA$442,829
2024National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866CYTOPLASMIC CHROMATIN FRAGMENTS IN CELL SENESCENCE - NOVEL MECHANISMS AND INTERVENTIONS - PROJECT SUMMARY CELLULAR SENESCENCE IS A CAUSE OF CELL AND TISSUE AGIN$428,501
2024National Institutes of HealthGrant or other assistanceCANCER BIOLOGY RESEARCH 93.396MOLECULAR PATHOGENESIS OF AF10-REARRANGED LEUKEMIAS - PROJECT SUMMARY THERE HAS BEEN CONSIDERABLE PROGRESS IN THE LAST FEW YEARS IN THE CHARACTERIZATION OF MOLE$427,097
2024National Institutes of HealthGrant or other assistanceCANCER BIOLOGY RESEARCH 93.396NON-CANONICAL PHOSPHATIDYLINOSITOL KINASES IN TRIPLE NEGATIVE BREAST CANCER$423,760
2024National Institutes of HealthGrant or other assistanceCANCER TREATMENT RESEARCH 93.395TARGETING THE FBXO44/SUV39H1 PATHWAY IN CANCER - PROJECT SUMMARY REPETITIVE ELEMENTS (RES) COMPOSE ~45% OF THE HUMAN GENOME AND ARE NORMALLY TRANSCRIPTIONALLY S$423,760
2024National Institutes of HealthGrant or other assistanceCANCER TREATMENT RESEARCH 93.395TARGETING ER+ BREAST CANCER THROUGH INDUCED VIRAL MIMICRY - PROJECT SUMMARY REPETITIVE ELEMENTS (RES) COMPOSE ~45% OF THE HUMAN GENOME AND ARE NORMALLY TRANSCRI$423,760
2024National Institutes of HealthGrant or other assistanceDIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847AUGMENTED NOTCH SIGNALING AS A THERAPEUTIC APPROACH FOR ALAGILLE SYNDROME - PROJECT SUMMARY ALAGILLE SYNDROME (ALGS) IS AN AUTOSOMAL DOMINANT DISORDER CHARACTER$411,840
2024National Institutes of HealthGrant or other assistanceVISION RESEARCH 93.867RETINOIC ACID TARGET GENES AND TRANSCRIPTIONAL MECHANISMS DURING EYE DEVELOPMENT - PROJECT SUMMARY ONE OF THE MOST CRITICAL FUNCTIONS OF THE VITAMIN A (RETINOL)$390,000
2024Defense Health AgencyGrant or other assistanceMILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420WHITE ADIPOSE TISSUE SURROUNDING LYMPH NODES MODULATES ANTIMELANOMA IMMUNITY MODIFICATION P00001 TRANSFERRED AWARD TO CEDARS SINAI MEDICAL CENTER$314,470
2024National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866EPIGENETIC REPROGRAMMING TO COUNTERACT NEURONAL AGING AND DEGENERATION - PROJECT SUMMARY/ABSTRACT THE AGING BRAIN IS INCREASINGLY SUSCEPTIBLE TO COGNITIVE DECLI$248,999
2024National Institutes of HealthGrant or other assistanceAGING RESEARCH 93.866THE AGING PANCREAS AS A PRO-TUMORIGENIC NICHE - PROJECT SUMMARY AGE IS A MAJOR RISK FACTOR FOR PANCREATIC DUCTAL ADENOCARCINOMA (PDAC), WITH THE INCIDENCE OF PD$243,750
2024National Institutes of HealthGrant or other assistanceEXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853SPATIAL REGULATORS OF SKELETAL MUSCLE REGENERATION AND DISEASE - SKELETAL MUSCLES ARE RESPONSIBLE FOR MOVEMENT, BREATHING, POSTURE AND METABOLISM. LOSS OF MUSCL$241,260
2024National Institutes of HealthGrant or other assistanceCANCER BIOLOGY RESEARCH 93.396DEVELOPMENT AND IMPLEMENTATION OF ADVANCED TECHNOLOGIES FOR CANCER METABOLISM RESEARCH - PROJECT SUMMARY THIS PROPOSAL REQUESTS SUPPORT FOR MY POSITION AS THE D$142,032

State business registration

The same business name in the same state, from the state’s official registry data.

Patents

101 US patents filed in the last 20 years.

PatentTitleGrantedSource
US 12741940Dopamine receptor d1 agonists and methods of use2026-09-22PTBLXML, file of 2026-09-22
US 12729208Inhibitor of apoptosis (IAP) protein antagonists2026-09-08PTBLXML, file of 2026-09-08
US 12708673Methods and compositions related to peptides and proteins with c-terminal elements2026-08-18PTBLXML, file of 2026-08-18
US 12678509Inhibitor of apoptosis (IAP) protein antagonists2026-07-14PTBLXML, file of 2026-07-14
US 12643910Substituted pyrazolo[3,4-b]pyridines as ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) modulators2026-06-02PTBLXML, file of 2026-06-02
US 12637436Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof2026-05-26PTBLXML, file of 2026-05-26
US 12594277Macrocyclic ULK1/2 inhibitors2026-04-07PTBLXML, file of 2026-04-07
US 12590336Role of PVT1 in the diagnosis and treatment of MYC-driven cancer2026-03-31PTBLXML, file of 2026-03-31
US 12534729Uses of synthetic lethal partners for treatment of cancer2026-01-27PTBLXML, file of 2026-01-27
US 12516085Methods and compositions for treating Myc-driven cancers2026-01-06PTBLXML, file of 2026-02-13

The newest patents of the PatentsView assignees above, matched to this record by name (and state).

Trademarks

2 US trademarks, 0 live.

MarkSerialFiledStatusSource
SBP870147112016-04-26Registration cancelledTRCFECO2, file of 2024-03-27
SCIENCE BENEFITING PATIENTS870146992016-04-26Registration cancelledTRCFECO2, file of 2024-03-27

The newest marks of the trademark owners above, matched to this record by name (and state).

In the news

2,073 news articles name this organization (June 2015 to November 2026); the latest 10:

News article metadata and links: The GDELT Project (https://www.gdeltproject.org/). Matched by: Exact name match: "sanford burnham prebys medical discovery institute". A shared name is not proof of the same organization; how the matching works. Most in the news.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationSanford Burnham Prebys Medical Discovery InstituteCAState business registriesname and state
Business registrationSanford Burnham Prebys Medical Discovery InstituteCAState business registriesname and state
Business registrationSANFORD-BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, INC.FLState business registriesEIN (EXACT, as the state registration reports it)
CollegeSanford Burnham Prebys Medical Discovery InstituteCAColleges and universities (IPEDS)name and state
Plan sponsorSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTECAForm 5500 (employee benefit plans)EIN (EXACT)
Federal award recipientSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTECAFederal spending (USAspending)name and state
Patent assigneeSanford Burnham Prebys Medical Discovery InstituteCAPatents (USPTO)name and state
Trademark ownerSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTECATrademarks (USPTO)name and state

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

NTEE code Biomedicine, Bioengineering Research, CA first:

More with this interest.

In other datasets, the same topic (Medical research) in CA:

Interests: Biomedicine, Bioengineering Research · abuse:substance · men:issues · science:research_education · space:outer · survivor:cancer · Medical research

The area Census

San Diego CountyCensus Tract 83.12

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Census Tract 83.12, San Diego County, California, county San Diego County, CA, state California; placed by its ZIP code. The tract is the tract holding most of the record's ZIP code (FURP does not geocode street addresses).

  • DAVID BRENNER was paid $1,345,526, 12.7 times the median household income in San Diego County, CA ($106,268), where 10.3% of residents live in poverty.
  • Revenue of $114,401,821 is $35 per resident of San Diego County, CA (population 3,288,774).
  • That revenue equals 0.09% of all household income in San Diego County, CA (1,171,278 households at the median $106,268, about $124,469,370,504).
  • 611 employees is 0.2 per 1,000 residents of San Diego County, CA.
MeasureCensus tract
Census Tract 83.12, San Diego County, California
County
San Diego County, CA
State
California
Population B010034,1473,288,77439,287,377
Population, 2020 census P13,7873,298,63439,538,223
Median age B0100245.537.337.9
Under 18 B0100115.6%20.9%22.0%
65 and over B0100128.1%15.4%15.7%
Households B110011,6771,171,27813,548,091
Foreign born B0500226.6%22.8%27.0%
Median household income B19013$143,847$106,268$99,122
Median family income B19113$197,625$122,377$113,346
Per capita income B19301$91,044$51,976$49,513
Poverty rate B170018.4%10.3%12.0%
Unemployment rate B230255.4%6.1%6.6%
Civilian labor force B230251,8631,689,38420,068,466
Mean commute (minutes) B0801318.125.528.7
Bachelor's degree or higher B1500371.5%43.2%37.1%
Housing units B250011,9221,250,64114,644,735
Owner-occupied B2500369.4%54.6%55.9%
Renters B2500330.6%45.4%44.1%
Median home value B25077$2,000,001$854,700$734,700
Median gross rent B25064$2,384$2,246$2,036
White, not Hispanic B0300263.3%42.4%33.8%
Black B030020.2%4.4%5.2%
Hispanic or Latino B0300219.4%34.6%40.2%
Asian B0300211.1%12.1%15.3%
American Indian and Alaska Native B030020.2%0.2%0.3%

Economy now FRED unemployment 5.1% in Sep 2026 (5.5% a year earlier); per capita personal income $90,957 in 2025, up 30% in five years (+4.3% after inflation); Unemployment rate: 5.5% in Sep 2016 to 5.1% in Sep 2026; low 3.8%, high 16.1% the state; Source: FRED, Federal Reserve Bank of St. Louis.

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Census Tract 83.12, San Diego County, California.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.